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Abstract  
Cynara Cardunculus var. Scolymus, usually known as artichoke, is a Mediterranean 
specie with therapeutic properties, including antioxidant activity. This plant is a rich 
source of polyphenols, including caffeoylquinic and dicaffeoylquinic acids. The use of 
bioactive ingredients or phytochemicals extracted from plant tissues in cosmetics is 
increasing, thus artichoke extract due to its constituents can be incorporated in topical 
formulations. 
The artichoke extract used in this study was obtained through an infusion technique, a 
conventional method in which dried leaves are placed in boiling water for a short period 
of time. Aqueous artichoke extract was characterized by high-performance liquid 
chromatography–diode array detector and a quantification of several constituents present 
in it, like proteins, carbohydrates, polyphenols and dietary fibers, was performed. Two 
purification strategies were adopted, including a gastric digestion followed by a dialysis 
that resulted in artichoke fraction A and a mucilage precipitation method. In this last 
method, two different assays were performed, one using acetic acid and the other without 
the use of acetic acid, resulting in artichoke fractions B and C, respectively. The purify 
fraction with higher polyphenols content was artichoke fraction C, which was chosen 
among all. The content of total phenols and tannins were determined along the 
purification processes, as well as the antioxidant activity. 
Artichoke Extract and Artichoke Fraction C were subjected to ROS scavenging activity 
and MTT cytotoxicity assays in HaCaT cell lines, being both good antioxidants and non-
toxic. Sun protection factor (SPF) was also measured in both fractions and the artichoke 
extract showed the highest SPF. 
These fractions were incorporated in O/W emulsions and hydrogels for topical 
application. Chemical and physical characterization and microbiological control, as well 
as cytotoxicity and membrane integrity assays, were performed on the products to ensure 
their quality and safety.  
The formulations containing the artichoke extract were considered the best choice 
according with the in vitro studies realized and the costs and time of production of each 
fraction, so these were chosen to proceed with the study. 
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ROS scavenging activity assays of the formulations containing artichoke extract showed 
powerful antioxidant activities. In vivo studies, including a human repeat insult patch 
testing (HRIPT) and an assessment of the protective effect against oxidative stress after 
UV radiation by chromameter evaluation, showed very good skin compatibility and no 
allergenic potential for all formulations, and according to the antioxidant activity assay, 
the artichoke gel was the formulation that presented a true in vivo antioxidant activity.  
The aim of this study was to investigate the antioxidant properties of artichoke extract in 
topical formulations.  
 
Key words: Cynara Cardunculus var. Scolymus; artichoke; purification strategies; 
phenols; antioxidant activity; topical formulations; sun protection factor (SPF). 
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Resumo 
Cynara Cardunculus var. Scolymus, usualmente conhecida por alcachofra, é uma espécie 
pertencente à família Asteraceae e é característica da região Mediterrânea, sendo um dos 
vegetais amplamente consumidos nessa região. Assim, esta espécie representa uma 
importante fonte de rendimentos para a agricultura e economia dos países mediterrâneos, 
sendo Espanha, França, Itália e Grécia responsáveis por mais de 45% da produção 
mundial de alcachofra. 
A alcachofra é maioritariamente composta por água, proteínas, lípidos, hidratos de 
carbono, inclusive inulina, fibras e açucares, mas também apresenta na sua constituição 
minerais e vitaminas. Esta espécie é ainda altamente rica em polifenóis, especialmente 
em derivados de ácido cafeoilquínico, como é o caso do ácido clorogénico (3-O-ácido 
cafeoilquínico) e da cinarina (1,3-ácido cafeoilquínico), e ainda em flavonoides como o 
cinarósido (7-O-glucósido de luteolina). Estes são responsáveis pela atividade 
antioxidante associada à alcachofra, sendo que quanto maior o seu conteúdo em 
polifenóis, maior a sua capacidade antioxidante. Para além da sua atividade antioxidante, 
a alcachofra é conhecida pelas suas amplas propriedades terapêuticas: colerética, 
hepatoprotetora, anticarcinogénica, antibacteriana, antifúngica, anti-inflamatória e anti 
envelhecimento.  
Os compostos bioativos presentes em tecidos vegetais, tais como os polifenóis, são 
extraídos através de inúmeras técnicas, sendo que este processo depende de diversos 
fatores, como é o caso do pH, solubilidade, tempo de extração e temperatura. A escolha 
do método de extração é fundamental e de extrema importância uma vez que influencia a 
taxa de extração, o rendimento e a pureza dos compostos extraídos. A infusão é um 
método de extração convencional, no qual as folhas da espécie em causa são introduzidas 
em água a ferver por um curto período de tempo, sendo o tempo de extração e a 
temperatura os parâmetros com maior impacto. Estes métodos de extração resultam em 
frações com elevado nível de impureza. Assim, a purificação dos extratos através da 
remoção de materiais maioritariamente inertes é uma opção que visa a obtenção de 
frações com propriedades melhoradas, incluindo a atividade antioxidante. A digestão 
ácida com suco gástrico seguida de uma diálise e a precipitação de mucilagens presentes 
nos extratos vegetais são duas estratégias de purificação. 
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A aplicação destes compostos em produtos cosméticos tem vindo a aumentar devido à 
proibição de utilização de ingredientes de origem animal e à procura de produtos naturais 
e sustentáveis. 
As formulações tópicas que têm por base extratos de origem vegetal têm como principais 
funções a proteção da pele contra efeitos exógenos e endógenos prejudiciais, e a 
manutenção do equilíbrio hidrolipídico da pele. E estas podem ser líquidas, tais como 
suspensões, soluções ou emulsões, ou semissólidas, como é o caso de pomadas, cremes e 
geles. As formulações semissólidas são preferíveis, dado que os ingredientes bioativos 
quando incorporados nestas podem ter ação nas camadas mais superficiais ou nas 
camadas mais profundas da pele, dependendo das características físico-químicas dos 
ingredientes bioativos e da finalidade das formulações, e ainda devido ao seu 
comportamento reológico. A qualidade, segurança e eficácia destes produtos são 
avaliadas através de diversos parâmetros físico-químicos, como o pH, homogeneidade e 
textura, através controlo microbiológico e estudos de irritabilidade cutânea, de 
citotoxicidade e de estabilidade, e ainda por parâmetros biométricos, tais como perda 
transepidérmica de água, hidratação, reforço da barreira cutânea, elasticidade, entre 
outros.  
O objetivo deste trabalho foi estudar as propriedades antioxidantes do extrato de 
alcachofra e a sua utilização como ingrediente para produtos cosméticos antioxidantes.  
O presente estudo utilizou folhas de alcachofra, as quais foram submetidas a um processo 
de infusão, de filtração e liofilização com o intuito de extrair e estabilizar o extrato de 
alcachofra. A caracterização do extrato de alcachofra foi realizada através de métodos de 
quantificação específicos e revelou que este é constituído por 62.8% de fibras dietéticas 
solúveis e insolúveis, 3 % de polifenóis, 0.82% de hidratos de carbono e 0.002% de 
proteínas. 
Duas estratégias de purificação foram adotadas visando o melhoramento das atividades 
antioxidantes do extrato de alcachofra: digestão ácida seguida de uma diálise com duração 
de 24 horas que resultou na fração A, e precipitação de mucilagens, na qual se testou 
ainda a importância da utilização de ácido acético, que resultaram nas frações B 
(utilização de ácido acético) e C (ausência de ácido acético). Os extratos aquosos 
procedentes das purificações, bem como o extrato aquoso de alcachofra, foram analisados 
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através de cromatografia líquida de alta eficiência (HPLC-DAD) com o intuito de 
acompanhar os processos de purificação e de dosear a cinarina, o ácido clorogénico e o 
cinarósido presente em cada fração. Estes compostos foram identificados em todas as 
frações estudadas, sendo que o extrato de alcachofra demonstrou ser o mais rico.  
A atividade antioxidante de todas as frações foi avaliada através do ensaio com o radical 
livre 1,1-diphenyl-2-picrylhydrazyl (DPPH). Todas as frações apresentaram atividade 
antioxidante, sendo que a fração que apresentou o melhor resultado foi a fração C, 
resultante da precipitação de mucilagens sem a utilização de ácido acético, com um EC50 
de 56 µg/mL.  
O extrato de alcachofra e a fração C foram estudados de forma mais detalhada. A sua 
atividade antioxidante foi ainda avaliada através de ensaios in vitro em queratinócitos, 
nos quais foram utilizados como agentes oxidativos o peróxido de hidrogénio e radiação 
UV. Ambas as frações não apresentaram diferenças significativas relativamente ao ácido 
ascórbico no caso da radiação UV, mas apresentaram ligeiras diferenças no caso do 
peróxido de hidrogénio.   
O fator de proteção solar (FPS) foi determinado, tendo-se obtido um FPS de 10.99 para o 
extrato de alcachofra e 10.20 para a fração C. A citotoxicidade foi também avaliada e 
apesar de se ter observado redução da viabilidade celular, os extratos foram considerados 
seguros. 
Ambas as frações foram incorporadas em dois tipos de formulações tópicas: emulsões 
O/W e geles. Ambas as formulações foram desenvolvidas com a máxima simplicidade 
possível, tendo-se utilizado apenas os ingredientes essenciais de forma a diminuir 
possíveis efeitos secundários provocados por algum ingrediente presente. Para cada 
formulação foi realizada uma caracterização físico-química (pH, viscosidade), e um 
controlo microbiológico. O pH ligeiramente acídico, entre 5.4 e 6.4, as propriedades 
reológicas e a quase total ausência de fungos e bactérias nos produtos cosméticos 
desenvolvidos, revelaram que estes são adequados e seguros para o uso tópico.  
Nos ensaios de citotoxicidade das formulações em queratinócitos observou-se uma 
diminuição da viabilidade celular associada às formulações que continham os 
ingredientes bioativos relativamente aos seus respetivos brancos. A nível da integridade 
membranar, apenas os cremes revelaram diferenças significativas quando comparados 
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com o seu branco. Assim, as formulações foram consideradas biocompatíveis e seguras 
para o uso tópico.  
Tendo em conta os resultados dos estudos in vitro e os custos e tempo de produção de 
cada fração (extrato de alcachofra e fração C), foi decidido testar apenas as formulações 
contendo o extrato de alcachofra nos seguintes estudos in vitro e nos estudos in vivo.  
As atividades antioxidantes das formulações com o extrato de alcachofra incorporado 
foram avaliadas através de ensaios in vitro em queratinócitos, nos quais se utilizou 
peróxido de hidrogénio e radiação UVB como indutores de stress oxidativo. Os resultados 
demonstraram que ambas as formulações, creme e gel, apresentam atividades 
antioxidantes elevadas. Nos estudos in vivo, foram realizados um Human Repeat Insult 
Patch Testing (HRIPT) e um ensaio para determinar o efeito de proteção das formulações 
contra stress oxidativo induzido por radiação UV. Os resultados demonstraram que ambas 
as formulações, o creme e o gel, apresentam uma boa compatibilidade cutânea, e que 
apesar de ambas as formulações possuírem a capacidade de diminuir a atividade oxidante 
provocada pela radiação UVA, apenas o gel de alcachofra demonstrou uma atividade 
antioxidante verdadeira.  
O processo de infusão demonstrou ser um método eficaz na extração de polifenóis da 
alcachofra. O mesmo ocorreu para os processos de purificação realizados, uma vez que 
estes conseguiram melhorar as atividades antioxidantes de cada fração, mesmo daquelas 
com um menor conteúdo de polifenóis. Através de ensaios in vitro, as formulações 
desenvolvidas com os extratos eleitos revelaram ser adequadas e seguras para o uso 
tópico. Posteriormente, estudos in vivo também demonstraram que estas formulações 
eram dermatologicamente seguras, uma vez que não apresentaram reações adversas na 
pele nem potencial efeito alergénico. Para além disso, estes estudos comprovaram de 
novo o potencial antioxidante da alcachofra, sendo que o gel que continha o extrato de 
alcachofra apresentou atividade antioxidante in vivo. 
Este estudo demonstrou assim o potencial da alcachofra para ser introduzido em produtos 
cosméticos com finalidades antioxidantes e anti envelhecimento.  
 
Palavras-Chave: Cynara Cardunculus var. Scolymus; alcachofra; estratégias de 
purificação; atividade antioxidante; formulações tópicas; fator de proteção solar (FPS). 
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1. Chapter: Introduction 
 
1.1. Cynara Cardunculus var. Scolymus 
1.1.1. The Domestication of Artichoke 
The artichoke was already known and cultivated at the beginning of the Christian era [1]. 
The first mention to this specie was made by Theophrastus, the Greek (371-287 BCE), 
who described artichoke cultivation in Sicily and Southern Italy [2], and in 77 EC the 
medical benefits of this plant were reported by the Roman Pliny the Elder (ad 23–79, in 
Naturalis Historia). However, it’s estimated that domestication of artichoke only occurred 
between 800 and 1 500 CE, possibly in monastery gardens [3]. Records point Filippo 
Strozzi as the first merchant of this specie, who was responsible for trading artichokes 
from Sicily to Florence in the beginning of 15th century [4]. 
 
1.1.2. Taxonomy and Botanical Description  
Cynara cardunculus var. scolymus, usually known as globe artichoke, belongs to the 
family Asteraceae, subfamily Carduoideae and genus Cynara. Wiklund used a cladistics 
method based on morphological characterization to search the ancestry of Cynara crops 
and the results showed that the cultivated artichoke (C. Cardunculus var. Scolymus), leafy 
cardoon (C. cardunculus var. Altilis) and wild cardoon (C. Cardunculus var. Sylvestris) 
are included in a single species: C. Cardunculus L. [5]. A more recent study analyzed the 
phyletic relationships between Cynara species by using internal transcribed spacer 
sequences of the ribosomal regions, and the results were nearly in accordance with the 
phylogeny proposed earlier by Wiklund [6]. In Figure 1.1 are represented harvested 
artichokes and its habitat. 
  
Figure 1.1 - Harvest globe artichokes at left and plant habit of globe artichoke at right. Illustrations removed from 
Edible Medicinal And Non-Medicinal Plants. 
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The globe artichoke is a perennial herbaceous plant, up to 80-180 cm tall, characterized 
by greyish green and deeply lobed leaves up to 75 cm in length. The flower heads are 5-
10 cm in diameter and consists of green bracts surrounding violet florets. Both bracts and 
florets are attached to a receptacle, commonly known as the heart [7]. 
At first the leaves of the globe artichoke are rosulate, but later they sprout and adopt an 
ovate-lanceolate shape. These leaves are silvery-grey, pinnatifid and normally large, up 
to 50 cm long by 20 wide. This specie is characterized by a voluminous ovate capitula, 
usually known as the head, which is characterized by a violet-blue flower that is placed 
on the top of the flowering stem, up to 1.5 m. This head is composed of thick, fleshy 
bracts called phyllaries (involucral bracts), which are broadly ovate and green or tinged 
with purple or wholly purple, and a fleshy base of the receptacle, also called heart. These 
are the edible parts of globe artichoke. 
 
1.1.3. Agroecology  
Globe artichoke has a wide adaptive range of 7-30°C, being a cool-season crop. 
Therefore, it should be planted in areas with day and night temperatures between 20-22°C 
and 12-14°C, respectively. This specie is very sensible to lower temperatures, and severe 
of frequent frosts can damage or kill it; but it tolerates well high temperatures (>30°C), 
though it tends to decrease the quality of artichoke heads. It also requires long periods of 
sunlight, having a critical photoperiod of 10.5 hours [8]. 
The transition from vegetative to reproductive phase in seed-planted individuals depends 
on the interaction between the size of the plant, low temperatures and photoperiod. This 
type of artichoke has deep-rooted and can grow in several varieties of soils. However, it 
grows best on deep, fertile and well-drained soils with a pH range of 6-8. It requires a 
raised-bed culture when drainage of the field isn’t known, since globe artichoke dislikes 
water-logged soils [8]. 
 
1.1.4. Geographic Distribution  
Mediterranean diet is characterized by a high consumption of vegetables, fruits, cereals 
and olive oil, which provide numerous micronutrients, such as vitamins, minerals, fibers 
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and polyphenols [9]. The artichoke is one of those vegetables, and it is consumed raw, 
boiled, steamed or fried, and therefore it’s used in numerous recipes [10]. 
This plant plays an important role in the agriculture and economy of the Mediterranean 
region, with a production of 199 900 t in Spain, 36 423 t in France, 547 799 t in Italy and 
28 600 t in Greece; it is also produced on a large scale in the North Africa – 777 671 t. 
Global production is approximately 1 793 016 t, making Mediterranean countries 
belonging to Europe – France, Spain, Italy and Greece – responsible for over 45% of 
artichoke production, which makes it a source of income that is helping the economy in 
this region [11].  
 
1.1.5. Phytochemistry 
The head of globe artichoke corresponds to 30-40% of its fresh weight [12] and the 
receptacle accounts for 33-55% of the head [13]. A raw globe artichoke is manly 
composed of water (84.94%); but it also contains proteins (3.27%), ash (1.13%), fat 
(0.15%), carbohydrates (10.51%), including inulin (1.8%), fibers (5.4%) and sugars 
(0.99%), such as glucose, fructose and sucrose. Minerals (0.66%) and vitamins (0.049%) 
are as well important components [14], [15].  
Carbohydrates are polyhydroxy aldehydes or ketones or substances that can originate 
such compounds through hydrolysis reactions, and they may be divided into three major 
classes: monosaccharides, oligosaccharides and polysaccharides. Plant polysaccharides 
can be classified into storage polysaccharide (e.g. inulin; the body can digest), cell-wall 
polysaccharides (e.g. cellulose; the body can’t digest it) and gums and mucilage. 
Structural fibers make up the plant cell walls and include lignin, cellulose, hemicelluloses 
and pectins.  
Globe artichoke has high content of carbohydrates, including the storage polysaccharide 
inulin. Inulin is a fructan-type polysaccharide that consists of (2→1) linked β-d-fructosyl 
residues (n = 2–60), usually with an (1↔2) α-d-glucose end group (degree of 
polymerization ranging from 2 to 60 or more). Previous studies report a content between 
1.8 and 2.5% of inulin in this plant [16], [17].  Fibers are also one of the most abundant 
constituents in the artichoke, namely cellulose and lignin. Cellulose is an unbranched 
glucose water-insoluble polymer with around 3 000 glucose units and it is the most widely 
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distributed component of plant cell walls, and lignin is phenylpropane polymers 
synthetized from coumatyl, coniferyl and sinapyl alcohols. Artichoke fibers are composed 
of 75.3 % of cellulose and 4.3% of lignin, being a rich-fiber plant [18]. Chemical structure 
of some compounds present in artichoke are showed in Figure 1.2. 
 
 
Phenolic compounds are one of the biggest and widely distributed groups of secondary 
metabolites in plants. All polyphenols share a common origin, the amino acid 
phenylalanine, which is deaminated to cinnamic or converted to tyrosine, and then it 
enters the phenylpropanoid pathway. Therefore, phenolic compounds have as a common 
characteristic, the presence of at least one aromatic ring hydroxyl-substituted. The 
polyphenols can be classified into simple phenols, hydroxybenzoic acid and 
hydroxycinnamic acid derivatives, flavonoids, stilbenes, lignans and hydrolyzable as well 
as condensed tannins. These compounds are usually bounded to other molecules, 
commonly sugars and proteins, but they also exist in a small quantity in their free form, 
possibly due to its toxicity when in free state. They play an important role in plants, 
Inulin  
Cellulose   
Lignin 
Figure 1.2 - Representative compounds present in the artichoke: inulin, lignin and cellulose. 
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namely in sensorial properties (color, aroma, taste and astringency), structure, pollination, 
resistance to pests and defense from predators and in grow, germinative and reproduction 
processes. According to literature, the outer and inner bracts, the receptacle and the leaves 
of globe artichoke contain polyphenols [10], [19], but its content can be influenced by the 
harvest time. The phenolic content can increase up to 16 times from winter to Spring 
harvest, especially in floral stem [20].  
Zhu et al. [21] identified four caffeoylquinic acid derivatives, chlorogenic acid, cynarin, 
3,5-di-O-caffeoylquinic acid and 4,5-di-O-caffeoylquinic acid, and four flavonoids, 
luteolin-7-rutinoside, cynaroside, apigenin-7-rutinoside and apigenin-7-O-β-D-
glucopyranoside in artichoke leaf extracts, and Falé et al. [22] also identified cynaroside 
(luteolin-7-O-glucoside) and luteolin-7-O-(6’’malonylglucoside). However, the 
artichoke extract is mainly composed of caffeoylquinic and dicaffeoylquinic acids, being 
the most abundant  cynarin (1,3-dicaffeoylquinic acid) and chlorogenic acid (3-O-
caffeoylquinic acid)) [19], [23]. Chemical structure of some phenolic compounds present 
in artichoke are showed in Figure 1.3. 
 
 
 
Cynarin 
Cynaroside 
Chlorogenic acid 
Figure 1.3 - Representative phenolic compounds in artichoke: cynarin, cynaroside and chlorogenic acid. 
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1.1.6. Therapeutic Properties 
Artichoke dried leaves have been used as a medicinal herb in traditional medicine for 
centuries because of its choleretic and hepatoprotective [24], anticarcinogenic[25], 
antioxidant [19], [22], [26], antibacterial [21], antifungal [27], anti-inflammatory [28] and 
antiphotoaging properties [29]. 
The hepatoprotective activity of artichoke was tested in isolated rat hepatocytes against 
CCl4 toxicity and the results revealed that cynarin and caffeic acid act in glutamine 
oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GTP), consequently 
showing hepatoprotective properties, while isochlorogenic acid and cynaroside act only 
in the GOT activity. Quinic acid and chlorogenic acid didn’t alter the toxicity of CCl4 
[30]. Another study showed that the artichoke leaf extract with the highest content in 
phenolic compounds exerted a more significant effect on bile flow and liver protection, 
but the results also showed that the administration of cynarin and chlorogenic acid as pure 
compounds didn’t revealed hepatoprotective or choleretic properties [24]. The 
investigators suggested that caffeoyl derivates have an important role in therapeutic 
properties of artichoke, but when administrated in their pure form, they aren’t effective. 
Mileo et al. [31] investigated the chemopreventive properties of artichoke edible parts 
through cytotoxicity assays on several cell lines and the results showed a similar level of 
toxicity in breast cancer cell lines but not any notable effects, even at high concentrations, 
on normal breast epithelial cells. This effect is due to the combined activities of several 
bioactive compounds present in the edible part of artichoke, since a study demonstrated 
that the artichoke extract has a faster and more pronounced apoptotic activity than the 
pure chlorogenic acid [32]. 
Through the measurement of the lag phase prolongation of conjugated diene formation, 
the decrease in the rate of propagation and a sparing effect on the a-tocopherol within the 
low density lipoprotein (LDL), artichoke extract showed to have the capacity to retard 
LDL oxidation in a dose-depend way. Pure luteolin revealed a lipid peroxidation 
inhibition similar to 20 µg/mL of artichoke extract, and luteolin-7-O-glucosine also 
showed a dose-dependent inhibition of LDL oxidation but was less effective than luteolin. 
Studies of cooper-chelating properties of these compounds suggested a potential role in 
the antioxidant activity of artichoke extract [33]. Artichoke has an EC50 of 123.1 ± 5.7 
µg/mL for DPPH scavenging activity and its biochemical activities (acetylcholinesterase 
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inhibition and DPPH scavenging activity) remain similar after gastric and pancreatic 
digestions [22].  
In order to examine the antimicrobial activities of artichoke leaf extract, three fractions 
of it in different solvents, chloroform, ethyl acetate and n-butanol, were tested by disk 
assays. The results demonstrated that at least six types of bacteria, including B. subtilis, 
S. aureus, A. tumefaciens and M. luteus, and five fungi, including C. albicans, S. 
cereVisiae, S. carlsbergensis, A. niger and P. oxalicum, were susceptible to all artichoke 
fractions [21]. However, C. lusitaniae and M. mucedo were only susceptible to n-butanol 
fraction and C. cucumerinum was sensitive only to n-butanol and chloroform fractions. 
Therefore, the n-butanol fraction was considered the most active to all microorganisms 
tested. In the same study, eight phenolic compounds were isolated from n-butanol 
fraction, including chlorogenic acid, cynarin, 3,5-di-O-caffeoylquinic acid, 4,5-di-O-
caffeoylquinic acid, luteolin-7-rutinoside, cynaroside, apigenin-7-rutinoside and 
apigenin-7-O-β-D-glucopyranoside, and the compounds that showed a higher 
antimicrobial activity were the chlorogenic acid, the cynarin, cynaroside and luteolin-7-
rutinoside. In following studies, artichoke leaf extract also showed antifungal activity 
against 7 foodborne bacterial pathogens, Bacillus subtilis, Staphylococcus aureus, 
Agrobacterium tumefaciens, Micrococcus luteus, Escherichia coli, Salmonella 
typhimurium and Pseudomonas aeruginosa, 4 yeasts, Candida albicans, Candida 
lusitaniae , Saccharomyces cerevisiae and Saccharo myces carlsbergensis , and 4 molds, 
Aspergillus niger , Penicillium oxalicum , Mucor mucedo and Cladosporium 
cucumerinum [27]. 
A group of 10 albino mice were administrated via oral with 10% infusion (dry plant) or 
20% (fresh plant) corresponding to 1 or 2 g/kg of several plants, and the analgesic and 
anti-inflammatory activities were measured by the number of contortions and Evans blue 
dye diffusion to the peritoneal cavity, respectively [34]. From 10 plants tested, artichoke 
was one of the two plants that showed powerful anti-inflammatory and analgesic activities 
[28]. In other study, elevated levels of proinflammatory cytokines in blood serum of 
patients with chronic viral hepatitis C were normalized after using artichoke preparations 
during the medical rehabilitation period.  
Cynaropicrin is a bioactive sesquiterpene lactone and its content in artichoke extracts 
ranges between 0.44-1.60 % [35]. The administration of this compound found to be 
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effective against photoaging of the skin through the inhibition of the nuclear factor kappa 
(NF-κB)-mediated transactivation of basic fibroblast growth factor (bFGF) and the matrix 
metalloprotease-1 (MMP-1) in a dose-dependent manner [29]. NF- κB is normally 
retained in the cytoplasm as an inactive complex but it is activated by UV radiation, which 
induces bFGF and MMP-1 production [36], [37]. Was also confirmed that in an in vivo 
mouse model, cynaropicrin is able to prevent skin photoaging, which is traduced in a 
hyperproliferation of melanocytes and keratinocytes [29]. 
 
1.1.7. Artichoke Waste Phytochemicals 
The waste produced by the artichoke processing industry, such as leaves, outer bracts and 
stems, can form up to 80-85% of total biomass of the material, and it is normally used as 
organic mass, animal feed [38], and fuel [39] and fiber production [40].  
In the artichoke waste were reported 45 phenolic compounds, including gallic acid; 
caffeoylquinic acid 1,2 and 3; dicaffeoylquinic acids 1,2,3,4,5,6 and 7; protocatechuic 
acid; esculin; chlorogenic acid; p-coumaric acid-O-glucoside isomers 1 and 2; 
eriodictyolglucuronide; rutin (quercetin-3-O-rutinoside); dicaffeoylquinic acid 
derivative; hyperoside (quercetin-3-O-galactoside); luteolin-7-O-rutinoside; cynaroside 
(luteolin-7-O-glucoside); isoquercitrin (quercetin-3-O-glucoside); luteolin-7-O- 
glucuronide; luteolin-7-O-galactoside; naringenin-O-hexoside; avicularin (quercetin-3-
O-arabinoside); isorhoifolin (apigenin-7-O-rutinoside); quercetin-O-pentoside; quercitrin 
(quercetin-3-O-rhamnoside); luteolin-7-O-neohesperidoside; apigenin-O-glucoside; 
prunin (naringenin-7-O-glucoside); naringin (naringenin-7-O-neohesperidoside); 
scolimoside (luteolin-7-O-rhamnoside); apigenin-7-O-glucuronide; quercetin-O-
pentoside; phloridzin (phloretin-2-O-glucoside); feruloylquinic acid-O-glucoside; 
luteolin; quercetin; naringenin; and apigenin chrysoeriol. Among all components, 
caffeoylquinic and dicaffeoylquinic acids showed to be the main components of artichoke 
waste [41]. 
Knowing the therapeutic properties of all artichoke components combined, the actual use 
of artichoke by-products is questionable and since it has several health benefits, 
alternatives for its use should be considered. Production of natural nontoxic food 
additives, neutraceuticals or cosmetics using artichoke as bioactive ingredient are some 
options for the use or artichoke by-products.  
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1.2. Purification Methods 
Extraction is the separation of active ingredients of plant tissues from the inactive or inert 
compounds through the use of selective solvents in standard extraction techniques.  The 
plant extracts obtained are still a relatively impure liquid, semisolid or powders and 
include several chemical compounds with different functions and structures, such as 
polyphenols [42]. The extraction of polyphenols from leaves depends on many factors 
including pH, solubility, extraction time and temperature [43]. However, the extraction 
method has effects on the rate, yield and purity of these compounds, so the method choice 
is crucial. 
Infusion is a conventional method, in which dried leaves are placed in boiling water for a 
short period of time. The temperature and extraction time are parameters with impact in 
the total polyphenol content and consequently in antioxidant activity [42]. Liang et al. 
[44] investigated the influence of temperature on the extraction efficiency and 
degradation of polyphenols in green tea. The results showed that at a temperature of 
100°C, the green tea catechins suffered alterations on their configuration to their isomers, 
and at 80°C the catechins epimerization was inhibited. Therefore, the extraction should 
be executed at a temperature between 80 and 100°C. Another study showed that a 
prolonged extraction period leads to the degradation of a large fraction of flavonoids 
present in green tea [45]. The investigators concluded that the conventional procedure of 
pouring boiling water to the cup with the herbal leaves and let it rest for 10 minutes is the 
proper way to infuse the herbs. This extraction technique is usually followed by a 
filtration procedure in order to separate the plant tissues from the solution containing the 
bioactive compounds. The vacuum filtration is a well-know and simple method that 
consists in passing the stream through a porous filter, which is capable of retaining the 
solids. This filtration requires a pressure drop in order for the liquid to flow through the 
filter, and this pressure can be achieved by creating a vacuum or a centrifugal force, by 
raising the pressure more than the atmospheric pressure or by designing to make use of 
gravitational force [46]. The vacuum filtration schematic is represented in Figure 1.4. 
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To finalize the active substances extraction procedure from herbs, a lyophilization of the 
herb infusion is required to remove its water content, which enhances its stability. To 
proceed to the lyophilization, the herbal infusion needs to be frozen in order to separate 
the solvent from the solutes, since the water forms ice crystals and the solutes will be 
confined in the interstitial region between those crystals. Then the pressure in the system 
is reduced and heat is applied to the frozen herbal infusion, which will lead to the 
sublimation of the ice crystals formed previously. A dried mixture, usually named cake, 
is the result of this process, but it may contain 5-10% (w/w) of water adsorbed onto its 
surface. In some cases, if the water content in the cake is still too high and consequently 
its stability isn’t the desired, a second drying is performed through the increasing of 
temperature and reducing of partial pressure of water vapor in the container [47]. The 
diagram of a lyophilization is represented in Figure 1.5. 
 
Figure 1.5 - Diagram of lyophilization steps of a liquid formulation. Figure 1.5.1. shows the liquid formulation, which 
is market by ‘A’, in a glass container with the lyophilization closure positioned for the drying process; Figure 1.5.2. 
shows the frozen ice-product matrix of the formulation, which is market by ‘B’; Figure 1.5.3. represents the primary 
drying process and the interstitial cake portion is denoted by region market as ‘C’; Figure 1.5.4. illustrated the 
completion of secondary drying. Figure 1.5.5. demonstrates the final product with the closure in its stoppered position. 
Illustration adapted from Lyophilization: introduction and basic principles. 
Figure 1.4- Flow diagram of a vacuum filtration system. Illustration removed from Biosolids Tratment Processes. 
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The herbal extracts obtained from the previous method are still impure, so a purification 
is required in order to enhance its properties, including the antioxidant activity. Two 
different approaches can be followed in order to purify the herb infusion: gastric digestion 
followed by dialysis and mucilage precipitation. 
Tagliazuchi et al. [48] investigated the bio-accessibility of the major classes of 
polyphenols from Red Globe grapes through an in vitro model that simulated some 
chemical (pH, temperature and bile salts) and biological (gastric and pancreatic enzymes) 
gastro-intestinal conditions. The investigators concluded that the content of bio-
accessible polyphenols, flavonoids and anthocyanins increases during gastric digestion, 
and that the gastric digestion has no effect on the stability of polyphenols. Therefore, it is 
advantageous to perform a gastric digestion of infusions in order to increase its bio-
accessible polyphenols content, which will consequently improve its health benefits. 
Afterwards, a dialysis is required to separate the polyphenols from other large and 
complex molecules present in the herbal infusion, and consequently purify it. Dialysis is 
a separation method, based on the differential diffusion, of solutes with different 
molecular size through a membrane. This procedure is considered slow but it is efficient 
in separating small solutes from large molecules, and due to its simplicity, it is a method 
of choice. In this technique, the solution to be dialyzed is inserted in a dialysis membrane 
and then it is placed in a container with water for some hours or even days. In this process, 
a way of stirring the solutions is advisable and for that purpose, a magnetic stirred can be 
used to gently move continuously the dialysis membrane [49]. 
Another purification method is the precipitation of mucilage, a polysaccharide mixture 
that can be found in plant tissues of higher plants, present in herbal infusions. Kim et al. 
[50] investigated the effects of pectic mucilage removal from cactus cladodes (Opuntia 
humifusa Raf) and the results showed that along with the mucilage elimination occurs an 
increase of total polyphenols, and since these compounds contribute to antioxidant 
activity, it also resulted in an enhanced antioxidant activity.  
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1.3. Oxidative Stress in Skin 
The skin covers the entire surface of our bodies and it corresponds approximately to 15% 
of total adult body weight, being the biggest organ in human body [51]. It consists of 
differentiated cells and tissues that perform several functions in our body, such as defense 
against other organisms, maintenance of body temperature and protection from external 
environment [52]. The protection of external physical, chemical and biological 
aggressions is due to a complex structure that has different tissues, like epithelial, 
connective, vascular, muscular and nervous, which are organized in three distinct layers: 
epidermis, dermis and hypodermis [51]. The skin also has several specialized structures 
with different functions called appendages (sebaceous, eccrine sweat and apocrine glands, 
and hair follicles). The epidermis is a tough stratified epithelium composed of cells with 
different embryonic origins, such as melanocytes, Langerhans cells, Merkel cells and 
mostly keratinocytes. It exhibits a progressive differentiation (keratinization and 
cornification) from the basal to the surface, which results in different appearances of cells 
from one layer to another [52]. Basal cells are attached to an underlying basal lamina in 
the innermost layer, and above this one is the stratum spinosum composed of prickle cells. 
Upward is a thin layer consisting of granular cells - stratum granulosum - which form a 
waterproof barrier, being this one of the most vital functions of the epidermis. This layer 
is attached to the outermost layer called corneal stratum, which consists of dead cell with 
no intracellular organelles. This cells rich in keratin are connected by a thin and tough 
layer of proteins, including cytoplasmic protein involucrin [53]. Epidermis is associated 
with some appendages like pisosevaceous follicles and sweat glands [51]. Skin layers are 
represented in Figure 1.6. 
Figure 1.6 - Basal cell layer (B), spinous layer (S), granylar layer (G) and stratum corneum in a hemtoxylin and eosin 
stains section of normal skin. Illustration from Freinkel et al, 2001. 
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Below the epidermis is the dermis, a connective tissue component of the skin that protects 
the epidermis and provides elasticity and support [51]. The dermis has less cells than the 
epidermis and it is composed of fibrous molecules, dermal cells, a ground substance, 
appendances, neurovascular networks and sensory receptors. Its function is to protect the 
body from physical injuries, to retain water, regulate the temperature and it has receptors 
of sensory regulation [52]. It has a continuous turnover system that regulates the synthesis 
and degradation of its protein and it’s composed of the papillary and reticular layers [54]. 
Papillary layer is the upper layer and it is formed of thin collagen fibrils that form thicker 
collagen fibers [54], cells (fibroblasts, dermal dendrocytes, mast cells), vessels and nerve 
endings, being this layer the connection between the dermis and epidermis [51]. Bellow 
this one is the reticular layer that is composed mostly of type I collagen and fibers, and 
has only about 15% of dermal collagen which is mostly found in the papillary layer [54]. 
The deepest part of the appendages, vascular and nerve plexures are retain in this last 
layer [51]. The deepest layer of the skin is the hypodermis that serves as a reserve of 
energy, protects the skin from mechanical injuries and has a role in thermoregulation [52]. 
This layer is mostly composed of large adipocytes with a very weakly osmiophilic 
cytoplasm, which show pericellular expression of S100 protein and vimentin [51]. The 
adipocytes are organized in primary and secondary lobules separated by connective tissue 
septa containing cells, such as fibroblasts, dendrocytes and mast cells [51]. The fat cells 
are in continuous renovation through the accumulation of lipids on their inside, 
proliferation of adipocytes and recruitment of undifferentiated cells from mesoderm. This 
continuous system appears to be regulated by a hormone released from adipocytes called 
leptin [52]. The hypodermis also accommodates vessels, nerves and the deepest part of 
sweat glands [51].  
In 1955, Denham Harman articulated an innovated biochemistry theory that suggested a 
correlation between oxygen radicals produced by the cells and the aging process. 
According to his theory, oxygen radicals such as HO∙ and HO2∙ were generated inside 
cells, most likely due to the interaction of respiratory enzymes and the molecular oxygen 
and to the action of catalase on hydrogen peroxide, and they were responsible for damages 
in DNA and proteins, and consequently for the ageing and cancer [55]. Despite the 
controversy around this theory back in those days, in the present day it is well proved.  
Skin is exposed to several harmful agents, such as ultraviolet (UV) and ionizing radiation, 
air pollution and biologic contaminants, that contribute for the production of reactive 
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oxygen species (ROS) in epidermal tissues. ROS are compounds derived from molecular 
oxygen, O2, but due to chemical reactions they have extra electrons, which make them 
unstable. Hydroxyl radicals, HO∙, are a result from homolytic cleavage of hydrogen 
peroxide, H2O2, and superoxide, O2∙, a result of molecular oxygen reduction. These two 
radicals and hydrogen peroxide are largely produced by the cells as a result of several 
biological mechanisms [56].  
Among differentiated cells, human keranocytes are the most exposed to harmful agents, 
including oxidative stress associated with ROS overproduction, and they are further 
modulated by exposure to UV radiation, chemical compounds, rich-oxygen environment 
and inflammatory processes. Orciani et al. [57] determined the susceptibility of isolated 
mesenchymal stem cells from human skin (S-MSCs) to oxidative stress and compared the 
results with keratinocytes, which are differentiated cells of the same lineage. Cells were 
exposure to H2O2, a stress oxidative inductor, for 2 hours and the oxidative stress effects 
were analyzed after 4, 12, 24 and 48 hours of recovery, and the data reported a greater 
antioxidant defense for the keranocytes, while stem cells, which are surrounded by a 
protective environment, weren’t able to overcome oxidative stress. However, human 
keranocytes can still suffer damage at a long-term exposition to harmful agents, like UV 
radiation [58]. 
At high levels, ROS can induce damage to cell structures, lipids, nucleic acids and 
proteins, which can contribute to mutagenesis, carcinogenesis and ageing [59]. Human 
organism have developed several defensive strategies, like preventative and repair 
mechanisms, and physical and oxidant defenses [59], but these are not always capable to 
respond to an ROS overproduction and occasionally some errors may occur. Therefore, 
the search for new compounds with the capacity of preventing these oxidative stress 
events is constant.  
UV radiation is divided in three distinct types of radiation: UVC (wavelength 200-280), 
UVB (wavelength 290-315nm) and UVA (315-400nm). The UVB and UVC are mostly 
filtered by the ozone layer, therefore only 5-10% of highly energetic UVB reaches the 
skin, being the rest UVA radiation [60]. The UVB radiation is mainly absorbed by the 
epidermis, while UVA radiation is able to penetrate into the dermis and it also interacts 
with the stratum corneum and epidermis [61]. There are some chromophores in the skin 
that can absorb UV radiation, such as melanin, DNA, RNA, proteins, lipids, aromatic 
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amino acids – tyrosine and tryptophan – and urocanic acid [62]. This absorption can lead 
to several photochemical reactions and secondary interactions with ROS, which can result 
in inflammation, photoaging, immunosuppression and skin cancers – cutaneous 
malignant melanoma, basal cell carcinoma and squamous cell carcinoma [61]. UVA and 
UVB radiation have different wavelength and therefore, they show distinct properties 
concerning their biological effects on our skin, being UVB radiation more mutagenic and 
cytotoxic than UVA. UVA radiation interacts with endogenous photosentisizers resulting 
in ROS production, which may cause damage to DNA, proteins and membranes. On the 
contrary, UVB radiation is highly absorbed by DNA resulting in its disruption and the 
production of photoproducts like cyclobutane pyrimidine dimers (CPD) and pyrumidone. 
A consequence of these photoreactions is the accumulation of defective DNA that can be 
the trigger to mutations of genes that regulate the tissue homeostasis and genome 
integrity, for example the p53 tumor suppressor gene [60]. UVB radiation modifies the 
epidermal morphology, including the thickness increase of the corneal stratum, 
modification of cell cohesion and mechanical integrity of corneal stratum and disruption 
of the permeability barrier, resulting in transepidermal water loss, changes in the lipids of 
corneal stratum and decreased corneal stratum hydration [61]. 
Polyphenols from plant tissues have been described as powerful antioxidants that can 
support the skin’s own antioxidant defense against oxidative stress when applied topically 
[63], [64]. These compounds also have photoprotective properties [65] and sun protection 
factor (SPF), which ranges between 7 and 29 for stilbenes, flavonoids and 
hydroxycinnamic acid homologues [66]. 
 
1.4. Topical Formulations 
Nowadays, plant extracts are being more used in cosmetic formulation, mostly due to the 
prohibition of the use of animal origin ingredients and to an increase search for 
ecofriendly and sustainable products. These plant extracts are very different from purified 
therapeutic agents, since plant extracts are more dilute and usually contain more bioactive 
ingredients that may be related chemically and therapeutically to the main component 
responsible for the desired effect [67]. The use of bioactive ingredients or phytochemicals 
extracted from plant tissues in cosmetics have two major purposes, including body care 
and as a source of nutrients for a healthy skin [68].  
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In cosmetics is possible to use the entire plant extract, which is mostly applied according 
with its known therapeutic effects, or selective plant extract, which is used according to 
the investigations studies on its properties [67]. Usually, these botanical products are rich 
in vitamins, hydrocolloids, proteins, antioxidants, essential oils and other bioactive 
compounds [69]. Cosmetic formulations containing bioactive ingredients from a natural 
source are designed to protect skin against exogenous or endogenous harmful agents and 
to equilibrate the dermal hydrolipid content, which suffers alterations due to ageing and 
dermatosis [67].  
To develop a good formulation, simplicity is required and the shorter the ingredient list, 
the better, since it diminishes the possible adverse effects due to a compound present in 
it and the costs of production. The formulation design has to balance the ingredients used 
in order to create a product stable and easy to apply, and that maintains its functions 
during manufacturing, on the shelf and during and after application.  
Topical dermatological products can be administered easily and they can be liquid, such 
as suspensions, solutions and emulsions, or semisolid, including ointments, gels and 
creams. Active ingredients incorporated in topical formulations can stay on the surface 
layers of tissues or can penetrate into deeper layers, depending on its physicochemical 
properties, its action and the formulation approach. 
Creams are semisolid emulsions made with two immiscible liquids, water and oil, in 
which one is considered the dispersion phase and it is dispersed into the other phase, 
which acts as the dispersion medium, resulting in a stable dispersion. The main 
ingredients of these formulations are emollients, humectants, surfactants, preservatives, 
chelating agents, perfumes and others. The equilibrium between water and oily 
ingredients may produce different formulations in order to suit different purposes (skin 
types, skin conditions, age of user and living environment). Usually, the main functions 
of creams are to maintain the moisture balance and keep the skin moist and supple by 
supplying water, humectants and oils [70]. There are two categories of creams according 
to the surfactants and oily ingredients used: O/W or W/O emulsions. In O/W emulsions 
are used hydrophilic surfactants and the oily ingredients can vary widely from non-polar 
to polar. On the contrary, in W/O emulsions are mostly used lipophilic surfactants and 
the oily ingredients are mainly non-polar. The W/O type has been used to increase the 
oily nature and the O/W type when a light feeling is wanted [70].   
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Gels are a type of base with a uniform external appearance that can vary from transparent 
to semitransparent and they provide a moist feeling. These formulations can be divided 
into two categories, aqueous or oily gels. Aqueous gels are used as a base material and 
are known for their water supplying, moisturizing and cooling effects. Oily gels supply 
oil to the skin and have moisturizing properties as well. The main compounds of gels are 
polymers and solvents [70]. Polymers are a crucial gel constituent and they can be 
classified based on source (natural, semi-synthetic and synthetic), structure (linear, 
branched chain, crosslinked or network polymer), polymerization type (addition or 
condensation polymers), molecular forces (elastomers, fibers, thermosetting, 
thermoplastic), chain growth polymerization (free radicals governed) or degradability 
(biodegradable or non-degradable) [71]. Water soluble polymers can be applied in several 
industries, like food, paint, textiles, paper, pharmaceuticals, cosmetics, water treatment, 
among others, and can be divided into two categories, synthetic or natural. Synthetic 
water soluble polymers can be dissolve, disperse or swell in water and can work as a 
gelation, thickening or emulsification/stabilization agent, which result in alterations of 
physical properties of aqueous systems. These include poly(ethylene glycol) (PEG), 
polyvinyl pyrrolidone (PVP), Polyvinyl alcohol (PVA), Polyacrylamides, Polyacrylic 
acid (PAA), N-(2-Hydroxypropyl) methacrylamide (HPMA), Divinyl Ether-Maleic 
Anhydride (DIVEMA), polyoxazoline, Polyphosphates and Polyphosphazenes; and 
natural water soluble polymers include xanthan gum, pectins, chitosan derivatives, 
dextran, carrageenan, guar gum, cellulose ethers, hyaluronic acid (HA), albumin and 
starch or starch based derivatives [71]. 
The quality, safety and efficacy of a topical formulation is evaluated by physical and 
chemical parameters such as pH, homogeneity, texture, microbiological control, skin 
irritation studies, cytotoxicity, stability and biometric parameters, including 
transepidermal water loss, hydration, strengthening the cutaneous barrier and elasticity, 
among others.  
Under normal physiological condition, skin has an acidic pH between 4.5 and 6.5 that 
depends on the region. The acidic skin pH contributes to the defense against 
microbiological or chemical agents, the skin barrier homeostasis and stratum corneum 
desquamation [72]. Therefore, since skin pH has several important biological functions 
and its change could compromise the functions of topical formulations, these should 
present a pH value similar to skin pH.  
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Rheology, the science that studies the behavior of materials when they are under the 
influence of external forces, is a fundamental parameter in the development of 
formulations, but also in its manufacturing and application, and to ensure long shelf-life. 
Viscosity and elasticity are the simplest rheological properties [73]. Newtonian fluids are 
viscous but not elastic materials, like water, that under the smallest force, spend all energy 
in flowing; and Hookian bodies are elastic but not viscous materials, like rubber, that 
spends the force applied to change its shape and stores the energy. The semi-solid 
formulations have both viscosity and elasticity, being characterized by complex 
rheological properties, which depends on their internal structure [70].  
Different rheological fluid behaviors are observed in topical formulations: shearthinning, 
dilatant fluids, thixotropic and rheopectic. A purely viscous fluid is said to be 
shearthinning and is characterized by a viscosity decrease along with a shear rate increase. 
In dilatant fluids, the apparent viscosity increases with increasing shear rate. 
Shearthinning and dilatant fluids are independent of time. At a constant shear rate, the 
shear stress decreases monotonically in the case of thixotropic fluids and the shear stress 
increases monotonically in rheopectic fluids. These last types are time dependent fluids 
[74].  
Topical formulations contain several ingredients, like oil, water and glycerin (source of 
carbon), and substances, like amino acids derivatives and proteins (source of nitrogen), 
that can encourage the growth of microorganism. Therefore, to assure its quality is 
necessary to add preservatives, which are able to suppress the proliferation of 
microorganisms that may have contaminated it and to kill them, thereby preventing the 
product deterioration. To assure the near or total absence of microorganisms, two methods 
are largely used in microbiological control: total aerobic microbial count (TAMC) and 
total combined yeasts and molds count (TYMC) tests [70].  
Human repeated insult patch testes (HRIPT) is one of the most used methods to evaluate 
the safety of finished cosmetics products, which is performed under exaggerated 
conditions of product exposure. This test requires a large group of subjects (100) and can 
be performed in several different manners with distinct exposure times and occluding 
methods. The subjects are exposed to the cosmetic products during a 3 weeks’ period, 
which is followed by a 2 weeks’ rest period. Afterwards, the challenge period is 
performed using a 24 or 48 h patch test and the resulting reaction is categorized for clinical 
19 
 
signs. The product concentration used is determined by prior sensitization test results 
performed in animals, results from repeated application irritation patch studies in humans 
and prior experience [75]. 
To study the efficacy of cosmetic products are used non-invasive techniques, such as 
elasticity, skin thickness, wrinkling, roughness, transepidermal water loss, hydration, 
strengthening the cutaneous barrier and elasticity, among others. These parameters can 
evaluate possible adverse reactions and changes that may occurred in the skin, hair or 
nails after the use of a cosmetic product.  
A cosmetic to be considered safe according to regulation (EC) N° 1223/2009, shouldn’t 
show adverse effects on normal or sensitive individuals like skin irritation, sensitization, 
phototoxicity and photosensitization.  
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2. Objectives 
The aim of this study was to investigate the antioxidant properties of artichoke extract in 
topical formulations. 
For this purpose, other tasks with a high interest were also proposed: 
 Increase the acknowledge of purification strategies of plant extracts that may be 
used posteriorly in other species studies and even in industrial processes; 
 Found new applications for this specie since it is highly produced and has an 
enormous economic value in the Mediterranean region.  
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3. Chapter: Materials and Methods 
 
3.1. Purification and Chemical Analysis  
3.1.1. Preparation of Artichoke Extract  
Cynara Cardunculus Scolymus bracts from DIATÉTICA® were acquired and an infusion 
with 91.02 g of it in 910.2 mL of boiled distilled water was performed for 10 minutes. 
This process was followed by a vacuum filtration with a 70 MM filter in order to remove 
the bracts from the aqueous part. 
3.1.2. Artichoke Extract Dialysis  
A gastric juice solution was prepared through the addition of 320 mg of pepsin and 200 
mg of NaCl to 100 mL of distilled water with a pH of 1.2, which was previously acidified 
with HCl 37%, and was also prepared a 50 mg/mL artichoke solution. A dialysis mix was 
prepared with 50% of gastric juice and 50% of artichoke solution, and then put in a bath 
at 37°C for 60 minutes. Afterward, this mix was added to a dialysis membrane, which 
was place inside of a goblet with 100 mL of acidified distilled water (pH 1.2) at room 
temperature. The dialysis process lasted 24 hours. The outer waters were exchanged a 
few times to prevent its saturation and were preserved in a recipient, and aliquots were 
collected during the process to evaluate its efficacy. 
3.1.3. Mucilage Precipitation 
In order to precipitate the mucilage present in the artichoke extract, two different 
approaches were adopted: a method found in literature using acetic acid [1] and the same 
method readapted without the use of acetic acid. 0.5 g of artichoke extract were dissolved 
in 25 mL of distilled water, and then this solution was added to 100 mL of A solution 
(96% ethanol and 1% 100% glacial acetic acid) or B solution (96% ethanol), according 
to the methodology chosen. A centrifugation at 2 600 g for 10 minutes was followed. The 
supernatant was separated from the pellet and reserved in a recipient for posterior 
lyophilization. The pellet was dried in a nitrogen line. The initial mass wasn’t always the 
same, but the reagent proportions used were always equal. The assay with use of acetic 
acid resulted in artichoke fraction B and the assay with no use of acetic acid in artichoke 
fraction C. 
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3.1.4. McCleary Method  
The McCleary method (AOAC 2009.01) was also performed with the purpose of 
precipitate the mucilage. The artichoke fraction C obtained from the mucilage 
precipitation method with no use of acetic acid, was the fraction chosen to perform this 
method.  
Initially, 30 mg of artichoke fraction C were dissolved in 2 mL of distilled water with a 
pH of 1.2 and then 2 mL of gastric juice were added, and then the mix was place in a 
water bath for 60 minutes at 37°C. After the first digestion, the mix was placed in the 
refrigerator for 60 minutes. A centrifugation at 2 600 g for 10 minutes at 4°C was 
followed, but it didn’t form any pellet. Afterwards, another digestion was performed 
adding 2 mL of pancreatic juice to the mix again. The pH of this mixture was adjusted to 
6.0 through the addition of 1 M NaOH. The mix was placed again in the water bath at 
37°C for 60 minutes, and then reserved again in the refrigerator for 18 hours. A 
centrifugation with the same conditions as before was realized, and the supernatant was 
separated from the pellet for posterior lyophilization and the pellet was dried in an azote 
line.  
The gastric juice was prepared adding 320 mg of pure pepsin and 200 mg of NaCl to a 
total volume of 100 mL of distilled water previously acidified with 37% HCl to a pH of 
1.2. The pancreatic juice was prepared adding 250 mg of pancreatin from porcine 
pancreas (8 × USP specifications) to a 50 M sodium phosphate buffer solution pH 8, 
which was prepared using 5 mL of Na2HPO4 sodium phosphate buffer solution and 5 mL 
of NaHPO4 sodium phosphate buffer solution. 
3.1.4. Samples Drying 
3.1.4.1. Lyophilization  
All samples obtained throughout the study were lyophilized in order to prevent its 
degradation. The samples were put in falcons or plastic recipients and then were 
lyophilized until its total dryness in a Heto PowerDry LL3000. 
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3.1.4.2. Solvent evaporation with rotary evaporator 
In order to separate the fractions from undesirable compounds, a solvent evaporation with 
rotary evaporator was performed at 60°C in a Büchi Rotavapor R-200. The period of time 
varied according with the time needed to evaporate all liquids present in the solution. 
3.1.5. High-Performance Liquid Chromatography (HPLC-
DAD)  
HPLC-DAD analysis were performed in order to quantify the chlorogenic acid, 
cynaroside and cynarin and to observe the compounds present in the dry extracts. The 
HPLC-DAD analysis was performed in an Elite LaChrom® VWR Hitachi liquid 
chromatograph equipped with a column oven L-2300 and Diode array detector L-2455 
(VWR, USA). The column LiChroCART® 250-4 LiChospher® 100 RP-8 (5 μm) was 
used. 
The method was already described [2]. It was used an injection volume of 25 μL with an 
auto injector and a flow rate of 1 mL/min. The detection was carried out between 200 and 
500 nm with a diode array detector. A gradient composed by solutions A (0.05% 
trifluoroacetic acid) and B (methanol) was used according as followed: 0 min, 80% A, 
20% B; 20 min 20% A, 80% B; 25 min, 20% A, 80% B. 
To quantify the chlorogenic acid, cynaroside and cynarin in the extracts obtained during 
the study, calibration curves were made using two different concentrations: 0.5 and 0.1 
mg/mL for chlorogenic acid and cynarin; 0.25 and 0.1 mg/mL for cynaroside.  
3.1.6. Total Phenolic Content with Folin-Ciocalteau Method 
The content of phenolic compounds in the fractions studied was determined according to 
the Folin-Ciocalteu procedure, using pure gallic acid as standard [3]. 
The calibration standard curve was obtained using six different concentrations of gallic 
acid (10, 20, 50, 100, 350 and 500 μg/ mL) and for blank was chosen the same solution 
without any gallic acid or sample. 
Was added 30 µL of sample, 1350 µL of distilled water and 30 µL of Folin-Ciocalteau 
reagent to an Eppendorf, and then it was subjected to vortex. Next, it rested for 3 minutes 
before adding 90 µL of sodium carbonate, and then it was set in continuous agitation in a 
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circular agitator at 18 rpm for 2 hours at 4°C. Finally, the absorbance was measured at 
760 nm in a Shimadzu UV-160A. 
3.1.7. Tannins Content with Prussian Blue 
The content of the tannins in the fractions obtained along the study was determined 
according to the Prussian Blue procedure, using pure tannic acid as standard [4]. 
The calibration standard curve was obtained using six different concentrations of tannic 
acid (10, 20, 40, 60, 100 and 150 μg/ mL) and for blank was chosen the same solution 
without any tannic acid or sample. 
Were added 50 µL of sample, 150 µL of distilled water, 150 µL of 0.1 M ferric chloride 
(in 0.1 M of HCl) and 150 µL of 0.008 M potassium ferrocyanide to an Eppendorf and 
the absorbance was measured at 605 nm in a Shimadzu UV-160A. 
3.1.8. Carbohydrates Content Measure 
The content of carbohydrates in the fractions obtained along the study was determined 
with the 3,5-dinitrosalicylic acid (DNS) assay, using monohydrated glucose (dextrose) as 
standard [5]. 
The calibration standard curve was obtained using six different volumes of glucose 1.5 
mg/mL (0.1, 0.2, 0.3, 0.4, 0.5 and 0.6 mL) and for blank was chosen the same solution 
without any glucose or sample. 
Were added 5 mg of sample and 1 mL of 95-97% H2SO4 to a test tube, and then it was 
boiled for 20 minutes. Afterwards, was added to the same tube 1.2 mL of 1M NaOH. The 
mix obtained was subjected to a vacuum filtration with a 70 MM filter and then it was 
placed in a 5 mL volumetric flask, which was make up to the mark with distilled water. 1 
mL was collected from the previous solution and added to an Eppendorf, along with 1 
mL of 3,5-dinitrosalicylic acid (DNS) and 2 mL of distilled water. This solution was 
boiled again for 5 minutes and then placed in a 25 mL volumetric flask, which was make 
up to the mark with distilled water. Finally, the absorbance was measured at 540 nm in a 
Shimadzu UV-160A. 
To prepare the DNS solution were added 0.5 g of DNS and 0.8 g of NaOH to 25 mL of 
heated distilled water and this process was performed in continuous magnetic agitation 
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until total dissolution of the compounds added. Afterwards, the solution was left until 
total cooling and then were added 15 g of tartrate and 25 mL of distilled water. 
3.1.9. Protein Content with Bradford Method 
The content of proteins in the fractions obtained along the study was determined 
according to the Bradford method, using bovine serum albumin (BSA) as standard [6]. 
The calibration standard curve was obtained using six different volumes of BSA (10, 20, 
40, 60, 80 and 100 μL) and for blank was chosen the same solution without any BSA or 
sample. 
Were added 5 µL of sample, 795 µL of distilled water and 200 µL of Bradford reagent to 
an Eppendorf and the absorbance was measured at 595 nm in a Shimadzu UV-160A. 
3.1.10. Flavonoid Content 
The content of flavonoids in the fractions obtained along the study was determined using 
a spectrophotometric assay based on aluminium complex formation, using catechin as 
standard [7]. 
The calibration standard curve was obtained using six different concentrations of catechin 
(10, 20, 50, 100, 200 and 500 μg/mL) and for blank was chosen the same solution without 
any catechin or sample. 
Were added 20 µL of sample, 480 µL of distilled water and 300 µL of NaNO2 (5% w/v) 
to an Eppendorf and the solution was left at room temperature for 5 minutes. Afterwards, 
were added 30 µL of AlCl3 (10% w/v) and another minute was waited before adding 200 
µL of 1M NaOH. The absorbance was measured at 510nm in a Shimadzu UV-160A. 
3.1.11. Cytotoxicity and Effects on Membrane Integrity Assays  
The cytotoxicity was evaluated using general cell viability endpoint MTT reduction (3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl- 2H-tetrazolium bromide) and propidium iodide 
exclusion assays [8], [9]. The MTT is a yellow water-soluble tetrazolium dye that is 
reduced to an insoluble-water purple formazan product by living cells. This last product 
when solubilized in an appropriate solvent can be measured spectrophotometrically, 
allowing the indirect determination of surviving number cells when exposed to a sample 
[10]. 
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Cell viability was assessed after 24h of incubation of a spontaneously immortalized 
human keratinocyte cell line HaCaT (CLS, Germany) with different concentrations of 
extracts. This assay required three days. In the first day, HaCaT cells were seeded in 
sterile flat bottom 96 well tissue culture plates (Greiner, Germany), in RPMI 1640 culture 
medium (Life Technologies, UK), supplemented with 10% Fetal serum bovine, 100 units 
of penicillin G (sodium salt) and 100 μg of streptomycin sulfate and 2mM L-glutamine 
(Life Technologies, UK), at a cell density of 2x105 cells/mL 100 microliters per well. 
Cells were incubated at 37° C and 5% CO2. On the second day, the medium was replaced 
by fresh medium and the artichoke extract, the artichoke fraction C or their respective 
formulations were added to six wells per plate. Then, cells were incubated for 24 h, 
negative control was the culture medium and positive control sodium dodecyl sulfate 
(SDS) at 1 mg/mL. In the third day, after the time of exposition, the medium was replaced 
by 0.3 mM propidium iodide in culture medium (stock solution 1.5 mM in DMSO, diluted 
with culture medium 1:5). Fluorescence was measured (excitation, 485 nm; emission, 590 
nm) in microplate reader (FLUOstar Omega, BMGLabtech, Germany), and then, the 
MTT assay was performed. Medium was replaced by medium containing 0.25 mg/mL 
MTT. The cells were incubated again for 3h. Afterwards, the medium was removed and 
the intracellular formazan crystals were solubilized and extracted with 100 µl 
dimethylsulfoxide (DMSO). After 15 min in continuous agitation at room temperature 
the absorbance was measured at 570 nm in FLUOstar Omega BMGLabtech Microplate 
Reader. 
The relative cell viability (%) compared to control cells was calculated for the MTT assay 
using the following equation: 
% cell viability = 
𝐴𝑏𝑠 𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑏𝑠 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
× 100 
Where Abssample is the absorbance measured for cells treated with artichoke extract or 
artichoke fraction C formulations and Abscontrol is the absorbance value obtained for cells 
incubated with culture medium in the cases of extracts and the absorbance values obtained 
for cells incubated with its blank in the cases of topical formulations, both measured at 
570 nm. 
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And for propidium iodide assay by:  
% cell viability = 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑠𝑎𝑚𝑝𝑙𝑒
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 
where Fluorescencesample is the relative fluorescence unit (URF) values obtained for cells 
treated with desired samples and Fluorescencecontrol is the URF values obtained for cells 
incubated with culture medium in the case of extracts and URF values obtained for cells 
incubated with its blank in the case of topical formulations. 
3.1.12. Antioxidant Activity 
3.1.12.1. 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay 
The 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay was used for determination of free 
radical-scavenging activity of the fractions, and the standard utilized was ascorbic acid 
[11]. DPPH is a stable free radical characterized by an unpaired valence electron at one 
atom of nitrogen bridge which bears a deep purple color, and when it’s neutralized 
becomes colorless or pale yellow. This method is based on measurement of the loss of 
DPPH color at 517 nm after reaction with samples [12]. 
The calibration standard curve was obtained using four different concentrations of the 
fraction tested (5, 10, 15 and 20 mg/mL) and for blank was chosen the same solution 
without any sample. Was added 1 mL of DPPH solution and 10 µL of sample to an 
Eppendorf and it was placed for 30 minutes at room temperature. Then the absorbance 
was measured at 517 nm in a Shimadzu UV-160A. 
The DPPH solution was prepared using 2 mg of pure DPPH and 100 mL of methanol. 
The percentages of inhibition of the DPPH free radical were calculated through the 
following equation:  
% of inhibition = 100 − (
𝐴𝑓
𝐴𝑏
∗ 100) 
Where Af is the absorbance measured for the fraction and Ab is the absorbance measured 
for the blank. Were realized three independent experiments and the results obtained are 
expressed as mean ± standard deviation. To calculate the half maximal effective 
concentration (EC50), which is required to scavenge 50% of DPPH free radicals, two 
approaches were adopted depending on the antioxidant profile observed. A linear 
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regression was opted for all fractions, with exception of artichoke extract. For this 
fraction, the EC50 value was obtained directly from the profile % of inhibition-
concentration obtained. 
3.1.12.2. Reactive Oxygen Species (ROS) Production 
Measurement 
The intracellular ROS production can be evaluated through a fluorimeter technique that 
uses 2,7’ dichlorodihydrofluorescein diacetate (H2-DCFDA, Life Technologies, UK). 
This molecule non-fluorescent is hydrolyzed to 2-7’-dichlorodihydrofluorescein 
(H2DCF), another non-fluorescent molecule, by the action of intracellular esterases. 
H2DCF is rapidly oxidized to a highly fluorescent compound (DCF) [13]–[15] in the 
presence of H2O2, hydroxyl radicals and several peroxides [16].  
In this assay were used HaCaT sub-confluent cells grown in 96 well plates, which were 
incubated for 30 minutes with 20 μM of H2-DCFDA in dark at 37°C. Later, the medium 
was removed and fresh medium was added to the cells before being exposed to different 
concentrations of extracts and ascorbic acid or topical formulations containing the 
extracts for 1 hour. In the case of the hydrogen peroxide (H2O2), it was added 
simultaneously with the samples in study. For the UV assay, three UV-B lamps (Sankyo 
Denki G8T5E, Kanagawa, Japan) with a peak emission at 312 nm were used as the UV-
B source, and measured with a VLX 312 radiometer equipped with a UV-B sensor (Vilber 
Lourmat, Marne-la-Vallée Cedex, France). The cells with the extracts or the topical 
formulations were irradiated with a UV-B single dose of 26 mJ/cm2 for 15 minutes. 
Afterwards, the ROS levels were determined at excitation 485 nm and emission 520 nm 
wavelengths using a florescence microplate reader (FLUOstar BMGLabtech, Germany) 
[17]. Data collected from at least 5 replicates is expressed as percentage of reduction of 
ROS. 
3.1.13. In vitro SPF determination 
All natural fractions, including artichoke extract, artichoke fraction C and green coffee 
oil, were accurately weighed (0.25 g), diluted with ethanol:water solution (1:1), followed 
by ultrasonication for 5 min and filtered through filter paper (WhatmanTM 42). The 
absorption spectra of samples solution were obtained in the range of 290 to 320 nm 
(Hitachi U-2001, USA) every 5 nm, using a standard 1 cm quartz cell, and ethanol:water 
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solution as the blank reagent. Triplicates were made, followed by the application of the 
Mansur equation: 
 
SPFspectrophotometric = CF x∑ 𝐸𝐸320290  () x I () x Abs () 
 
where EE () is the erythemal effect spectrum; I () is the solar intensity spectrum; Abs 
() is the absorbance of sunscreen product and CF is the correction factor (=10) [18]. The 
values of EE x I are constants determined by Sayre [19]. 
 
3.2. Topical Formulations Development 
3.2.1. Preparation of an emulsion and a hydrogel 
The emulsion was prepared through the combination of different ingredients, being the 
final formulation recipe in Table 3.1. Parabens sodium salts changed the emulsions colors 
to pale green, instead of pale beige, so in order get more stable formulations, parabens 
with no sodium were chosen. In total, three emulsions were prepared: blank cream (BC), 
cream containing artichoke extract (AC) and cream containing artichoke fraction C (CC). 
Table 3.1 - Percentage of ingredients in artichoke extract and artichoke fraction C emulsions. 
Ingredients 
Quantitative 
Composition (%, w/w) 
Polyglyceryl-3 Dicitrate/Stearate (Tego Care PSC3®) 3 
Cetearyl Alcohol (Tego Alkanol 1618®) 7 
Liquid Paraffin 2.5 
Decyl Oleate (Tegosoft Do®) 4.5 
Almond Oil 5 
Glycerin 5 
Purified Water 71.8 
Methylparaben (Nipagin®) 0.18 
Propylparaben (Nipazol®) 0.02 
Dry Artichoke Extract/ Dry Artichoke Fraction C 1 
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The process to prepared the emulsion involved the following steps: 
I. Adding the oily compounds (polyglyceryl-3 dicitrate/stearate, cetearyl alcohol, 
liquid paraffin, decyl oleate and almond oil) to a bowl and the non-oily compounds 
(glycerin and 70% of the purified water) to another bowl and place both bowls in a 
water bath at 70-80°C until total homogenization; 
II. Dissolving the extract in the remain purified water (around 30%) and reserve it; 
III. Verting the oily ingredients to the bowl containing the non-oily ingredients; 
IV. Taking the mix to ultra-turrax during 2-3 minutes; 
V. Adding the parabens to the mix while it is still warm; 
VI. Stirring the mix until it’s cold; 
VII. Adding the dissolved extract and then agitating the mix until it is homogeneous.  
 
The ingredients used to prepare the hydrogel are shown in Table 3.2. The polymer chosen 
to prepare the hydrogel was a carbomer, Carbopol 940®, which is a cross-linked 
polyacrylate polymer, that confers high viscosity, high suspending ability and high clarity 
to the formulation. The preservatives chosen were methyl and propyl parabens with no 
sodium. In total, three gels were prepared: blank gel (BG), gel containing artichoke 
extract (AG) and gel containing artichoke fraction C (CG). 
Table 3.2 - Percentage of ingredients in artichoke extract and artichoke fraction C hydrogels. 
Ingredients 
Quantitative Composition 
(%, w/w) 
Purified Water 86.48 
Carbomer (Carbopol 940®) 1.12 
Glycerin 11.2 
Methylparaben (Nipagin®) 0.18 
Propylparaben (Nipazol®) 0.02 
Dry Artichoke Extract/ Dry Artichoke Fraction C 1 
 
The process to develop the hydrogel involved the following steps: 
I. Adding all ingredients to a bowl, except the dry extract and some of the purified water; 
II. Dissolving the extract in the remain purified water and reserve it; 
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III. Adding the dissolved extract to the bowl; 
IV. Leaving the mix for 30 minutes at room temperature; 
V. Taking the mix to ultra-turrax during 2-3 minutes; 
VI. Adding sodium hydroxide to the mix until it gained the desired consistency. 
 
A blank for each formulation were also prepared to be used as control standards in the 
assays using the emulsions and gels.  
 
3.2.2. Formulations Rheology  
All formulations prepared, including their blanks, were analysed relatively to its 
consistency. Therefore, its viscosity was measured with a rotational digital viscometer 
Brookfield DV II and small sample adapter (SSA) – Brookfield Engineering Laboratories, 
EUA. The viscosity of the two formulations prepared, emulsion and hydrogel, were very 
distinct, so two spindles were used. For the emulsions was used the spindle nº 27 and for 
the hydrogels the spindle nº 7. Approximately 25 mL of formulation were placed in the 
recipient of the viscometer, and it was subdued to a continuous shear rate sweep (from 
0,6 to 122 s-1), keeping each shear rate for 15 seconds. 
3.2.3. pH Measurement 
The pH of each formulation were measured with the pH meter InoLab 730 WTW, at room 
temperature. At least three measures were performed for each emulsion and each gel, and 
the data were collected after stabilization of value on the equipment. 
3.2.4. Microbiological Control 
The microbiological stability assessment was performed according to the ISO 
16212:2008, ISO 21149:2006 and ISO 21148:2005 [20]–[22]. 
 
3.3. In Vivo Studies Analysis  
3.3.1. Human Repeat Insult Patch Testing (HRIPT) 
Marzully and Maibach HRIPT protocol [23] was used to performed a safety evaluation. 
For this study were chosen 50 healthy volunteers that were informed about the procedure 
and had signed the informed written consent. Volunteers with dermatological or other 
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medical or physical problems, and pregnant and nursing women were excluded from the 
study. The induction period of a possible allergic response lasted three weeks, in which a 
series of 9 patches (Finn Chamber standard) were performed. Each occlusive patch 
contained 20 mg of the formulation and was applied on the left side of the back. After 48 
hours, the patch was removed and was performed a skin evaluation, which was followed 
by the application of a new patch. Reactions after patching were measured according to 
the recommendations of the International Contact Dermatitis Research Group [24]. 
Induction period was followed by a two weeks’ rest period, in which wasn’t applied the 
tested product. Afterwards, challenge period started and new patches were applied again 
in the same way as in the induction period, but this time were applied in the right side of 
the back. After a period of 48 hours the patches were removed and skin evaluations were 
realized to observe possible skin reactions at 48, 72 and 96 hours after patching using 
again the score method recommended by the International Contact Dermatitis Research 
Group.  
This protocol was approved by the local Ethical Committee and respected the Helsinki 
Declaration and the AFSSAPS regulations on performed HRIPT studies on cosmetic 
products. This study was supervised by a dermatologist who participated in the skin 
evaluations in order to observe possible irritation/allergic reactions to the tested 
formulations. 
 
3.3.2. Assessment of the protective effect against oxidative stress 
after UV radiation by chromameter evaluation 
In the first day, three patches were applied in the forearm area (left or right) in each 
volunteer, two contained the formulations and the other one was the control, in which no 
product was applied. The patches remained 24 hours, and after this period, a solution of 
β-carotene was applied in the same area of the forearm. A negative control area with only 
β-carotene was also used. After 15 min of β-carotene application, the color was measured 
in all the areas. The areas were then irradiated with a UVA lamp and the color was 
measured again. A Minolta Chromameter CR-400 (Minolta, Japan) was used to obtain 
the b* color. The same area was evaluated at the first day (D0) and then after 28 days 
(D28) using the same procedure. Between D0 and D28, the volunteers applied the topical 
products in the areas indicated by the principal investigator. 
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3.4. Statistical Analysis  
Data was expressed as mean and standard deviation (mean ± SD) of experiments. 
Statistical evaluation of data was performed using one-way analysis of variance 
(ANOVA). Tukey–Kramer multiple comparison test (GraphPad PRISM 7® software, 
USA), was used to compare the significance of the difference between the groups, a P 
<0.05 was accepted as significant. 
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4. Results and Discussion 
4.1. Artichoke Extract 
The artichoke extract was chosen to be the main subject in this study due to its antioxidant 
properties and it was obtained through an infusion, followed by a lyophilization. Its 
chromatogram is showed in Figure 4.1. 
 
4.2. Purification of Artichoke Extract  
In order to purify the artichoke extract and to improve its properties, including antioxidant 
activity, two different purification approaches were addopted: an acidic digestion with 
gastric juice followed by a 24 hours dialysis, and a mucilage precipitation method. In this 
last one, the importance of acetic acid in the procedure was also investigated. The 
purification schematics is presented in Figure 4.2. 
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Figure 4.1 - Example of chromatogram of artichoke infusion (1mg/mL). 
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4.2.1. Acidic Digestion & Dialysis (Artichoke Fraction A)  
Tea infusions when ingested are exposed to gastric juice, and consequently to a complex 
system of enzymes and to a highly acidic pH (1.0-2.5) [1]. Pepsin is one of those enzymes 
and its optimum pH range is 1.5-2.5, which means that it has its maximum activity inside 
the stomach [2]. It can cleave the linkages between mucilage and phenolic compounds, 
enhancing the extraction of polyphenols from the artichoke extract during dialysis. 
Therefore, in order to maximize the extraction of polyphenols compounds from the 
artichoke extract, a dialysis with a previous acidic digestion of artichoke extract was 
made.  
To follow the progress of dialysis, aliquots of the permeate were collected along the assay. 
The permeate – the outer water where the retentate is placed - was exchanged three times 
to avoid saturation (3, 6 and 22 hour), which would probably slow down the polyphenols 
extraction. Over time was observed a change of coloration in the permeate, being the 
earlier samples colorless and the latest pale brown. This indicated that probably there was 
occurring an extraction from the artichoke extract to the permeate. This purified fraction 
will be called Artichoke Fraction A. 
Phenolic compounds present in each aliquot were measured through a well-established 
method of polyphenols quantification. It’s important to mention that the outer waters were 
exchanged after the hour 3, 6 and 22, so the values present in  
Figure 4.2 - Scheme of the purification strategies adopted to purify the artichoke extract.  
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Table 4.1 were not cumulative in the water. The maximum polyphenols mass was 
extracted after three hours of dialysis, meaning that a considerable quantity of 
polyphenols present in the artichoke extract were transferred from inside the dialysis 
membrane to the permeate in the first hours. In the following hours of dialysis, the rate 
of extraction decreased substantially, for example the mass of polyphenols extracted in 
16 hours – between the collection of the samples of hours 6 and 22 – was only 72 µg ( 
Table 4.1; Figure 4.3). The total polyphenols extracted during this process was the sum 
of all polyphenols present in the outer waters collected along the process (hours 3, 6, 22 
and 24). 
 
Table 4.1 - Quantification of polyphenols in artichoke fraction A after 3, 6, 22 and 24 hours of dialysis. 
Time (hour) Quantification of polyphenols (µg) 
3 295 
6 100 
22 72 
24 3 
 
 
Figure 4.3 - Quantification of polyphenols in each aliquot collected from the artichoke fraction A during the 24 hours 
of dialysis. 
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The HPLC-DAD chromatograms of the artichoke extract and the retentate – part of the 
extract that does not pass through the dialysis membrane – showed the presence of the 
same compounds in both fractions, since there are traces of every compound present in 
the artichoke extract in the retentate chromatogram (Figure 4.4). The same occurred in 
the HPLC-DAD chromatograms of the retentate and the artichoke fraction A (Figure 4.5).  
Figure 4.4 - Yield of compounds identified for artichoke extract and retentate obtained after dialysis by HPLC-DAD. 
  
Figure 4.5 - Yield of compounds indentified for retentate and artichoke fraction A, both obtained after dialysis, by 
HPLC-DAD. 
-20000
0
20000
40000
60000
80000
100000
0 5 10 15 20 25 30
A
ve
ra
ge
 A
b
so
rb
an
ce
 (
m
U
A
)
Time (minutes)
Retentate Artichoke Fraction A
-20000
0
20000
40000
60000
80000
100000
0 5 10 15 20 25 30
Artichoke Extract Retentate
44 
 
A control sample constituted by 50% water and 50% gastric juice was analyzed by HPLC-
DAD in order to compare with the rest of the chromatograms obtained from dialysis 
samples. In Figure 4.6, the retentate and digested artichoke extract (artichoke extract after 
the acidic digestion with gastric juice) chromatograms showed a peak at minute 25.2 that 
didn’t exist in the artichoke extract spectrum. However, this peak was also present in the 
control chromatogram, which suggests that it corresponds to the pepsin enzyme. This 
implies that the enzyme is not transferred from the retentate to the artichoke fraction A 
through the dialysis membrane, which complies with pepsin molecular weight (≈ 36 000 
Da) and the molecular weight cutoff of the membrane pores (10 000 Da). 
 
Figure 4.6 - Yields of compounds identified for the control sample, the retentate, the artichoke fraction A, the artichoke 
extract and the digested artichoke extract by HPLC-DAD. Control sample is 50% gastric juice and 50% water. Digested 
artichoke extract chromatogram is represented in a secondary vertical axis. 
 
4.2.2. Mucilage Precipitation (Artichoke Fractions B and C) 
Previous studies demonstrated the potential of polyphenolic-polysaccharide 
glycoconjugates isolated from medicinal plants of Asteraceae family as antioxidants, 
once they exhibited the capacity to protect proteins and lipids present in human plasma 
against oxidative stress caused by γ-radiation [3]. However, Kim et al. [4] showed that 
mucilage removal through an enzymatic hydrolysis from cactus cladodes resulted in an 
increase of phenolic compounds in the extract, and consequently in the improvement of 
its radical scavenging activity. Therefore, in order to remove the mucilage present in the 
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artichoke extract, a method found in literature was used [5]. This method had as purpose 
the improvement of the phenolic content of artichoke extract and consequently, its 
antioxidant activity. 
Initially, it was tested whether the presence of acetic acid affected the mucilage 
precipitation of the artichoke extract, in terms of phenolic compounds and antioxidant 
activity. Both assays were realized, one using acetic acid and the other without acetic 
acid, remaining the rest of the procedure equal. The supernatant obtained from the method 
using acetic acid will be called Artichoke Fraction B and the supernatant from the method 
without acetic acid will be named Artichoke Fraction C.  
 
4.3. Extracts Chemical Analysis 
4.3.1. Artichoke Extract 
4.3.1.1. HPLC-DAD Analysis 
Previous studies showed the presence of chlorogenic acid (5-caffeoylquinic acid), cynarin 
(1,3-di-O-caffeoylquinic acid) and cynaroside (luteolin-7-O-glucoside) in the artichoke 
extract [6]. Therefore, in order to investigate the presence of these compounds in the 
artichoke infusion previously prepared, a HPLC-DAD analysis was performed, being the 
chromatogram obtained in Figure 4.7.  
The retention times of chlorogenic acid, cynarin and cynaroside were approximately 7.38, 
12.4 and 12.65 min, respectively. So, the peak 1 indicated in Figure 4.7 corresponds to 
chlorogenic acid, the peak 2 to cynarin and the peak 3 to cynaroside.  
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Figure 4.7 – Example of chromatogram of artichoke infusion (1mg/mL). 
 
To measure these antioxidants in the artichoke infusion were performed several HPLC-
DAD analyses of chlorogenic acid, cynarin and cynaroside with well-known 
concentrations to create HPLC-DAD calibration curves, being the results in Table 4.2. 
Cynarin showed to be the most abundant antioxidant in the artichoke extract with 
aproximally 83 μg/ mg of artichoke extract, and chlorogenic acid revealed to be also in 
high levels with aproximally 56 μg/ mg of artichoke extract. This outcome is in accord 
with the literature, where chlorogenic acid and cynarin are showed to be the mainly 
compounds of Cynara C. Scolymus [7]. The flavone cynaroside is present in a smaller 
amount when compared with the two caffeoylquinic acids, with only 7 μg/mg of artichoke 
extract. Therefore, artichoke extract showed to be rich in phenolic compounds and 
flavones, which can explain its antioxidant activity. 
 
Table 4.2 – Total content of chlorogenic acid, cynaroside and cynarin in the artichoke extract. 
 Total Content (μg/mg of artichoke extract) 
Chlorogenic Acid 56 
Cynaroside 7 
Cynarin 83 
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4.3.1.2. McCleary Method  
In the mucilage precipitation method was observed a smaller amount of precipitate than 
it was expected, so was also realized the McCleary method. This method consists in two 
successive enzymatic digestions, the first with gastric juice and the second with pancreatic 
juice, and it was used to quantify the total dietary fibers present in the artichoke extract 
in order to characterize it. The artichoke fraction C was used in the beginning of this 
method. Its schematic is represented in Figure 4.8.  
Figure 4.8 - Scheme of the McCleary method. 
 
In order to follow the process, aliquots of the supernatants and precipitate formed were 
collected and posteriorly analyzed by HPLC-DAD. The chromatograms of the artichoke 
fraction C and the supernatants obtain during this method are represented in Figure 4.9, 
and some differences are spotted between them, like the peaks intensities as well as the 
appearing of new peaks and the disappearing of old ones. These results suggest that during 
the process, and due to the digestions by gastric and pancreatic juices, there are alterations 
in the artichoke extract, which are expected to lead to a more purified extract.  
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In the gastric juice digestion realized in the first purification method, dialysis, was 
observed the formation of a thin brown layer inside the dialysis membrane containing the 
artichoke extract, just like the layer observed also in the previous mucilage precipitation 
method, which means that the digestion of the extract using gastric juice results in the 
precipitation of mucilage. However, in this method, after the gastric juice digestion, 
wasn’t observed any layer and consequently, wasn’t formed any precipitate. This could 
be due to the previous mucilage precipitation method that resulted in the artichoke 
fraction C, which perhaps precipitated the all mucilage susceptible to the gastric juice 
enzymes. A closer look in the chromatograms of the artichoke fraction C and the 
supernatant SA, represented in Figure 4.10, shows that there are no significant differences 
between them, with exception of the peaks intensities. Therefore, this digestion didn’t 
affect the composition of the artichoke extract but according with the results showed in 
Table 4.3, there was an increase in the total content of phenolic compounds in the SA 
supernatant when compared with the content of the artichoke fraction C. 
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Figure 4.9 -  HPLC-DAD analysis of the artichoke fraction C (15 mg/ mL), and the supernatants SA (1,5 mg/ mL) and 
SB (1,3 mg/ mL). The artichoke fraction C is in a seconday axis (right one). 
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Table 4.3 - Total content of total phenols present in the artichoke fraction C and in the supernatants SA and SB. The 
data are presented as the mean ± SD of at least 3 replicates experiments. 
 
The chromatograms of the SA and SB supernatants shown in Figure 4.11 have some 
differences between them, including the appearing of the peak 1 and the nearly 
disappearing of the peak 2 in the SB chromatogram. These alterations are probably due 
to the pancreatic digestion, which results in the alteration of the artichoke extract 
composition. Bouayed et al. [8] studied the influence of intestinal digestion, which 
includes pancreatic juice, in the polyphenols of selected apple varieties. Changes in the 
polyphenolic profiles during intestinal digestion were observed and a considerable loss 
of polyphenols occurred. Another study reported the change of polyphenols after 
pancreatic digestion, which was traduced by the decrease of anthocyanins, flavonols, 
flavan-3-ols and neochlorogenic acid, and the increase of chlorogenic acid [9]. However, 
in this study was observed a slightly increase of total phenols after gastric and pancreatic 
digestion, being the results in Table 4.3. 
  Phenols (μg/ mg artichoke extract) 
Artichoke Fraction C 25 ± 0.78 
SA supernatant 30 ± 1.98 
SB supernatant 31 ± 3.68 
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Figure 4.10 - HPLC-DAD analysis of the artichoke fraction C (15 mg/ mL) and the supernatant SA (1,5 mg/ mL). 
50 
 
 
The HPLC-DAD analysis of the SB supernatant, the precipitate formed and the pancreatic 
juice, which chromatograms are presented in Figure 4.12 and Figure 4.13, suggests that 
a fraction of the pancreatic juice remained in the supernatant and another fraction 
precipitated with the mucilage. The peak 1 market in Figure 4.12, already marked before 
in the Figure 4.11, appears in the SB supernatant and in the pancreatic juice, but not in 
the SA supernatant, which indicates that this peak corresponds to a compound of the 
pancreatic juice, meaning that a part of it remained in the supernatant. On the other hand, 
the peaks 1 and 2 market in Figure 4.13 represent the compounds present either in the 
precipitate or in the pancreatic juice, indicating that a fraction of the pancreatic juice 
precipitates along with the mucilage. The precipitation of pancreatic juice compounds can 
possible be explained by the interactions between proteins and polysaccharides through 
an electrostatic complex or micellar structures formation [10], which perhaps are 
responsible for dragging the enzymes present in the solution, like pepsin and pancreatin, 
along with the polysaccharides.  
 
Figure 4.11 - HPLC-DAD analysis of the SA (1,5 mg/ mL) and SB (1,3 mg/ mL) supernatants. 
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The precipitate formed in the last step of this method had a total mass of 18.2 mg. But to 
assume that all of it corresponds only to mucilage, a calculation of the mass of pancreatic 
juice present in it was needed. The peaks 1 and 2 of the precipitate chromatogram market 
in Figure 4.13 corresponds to 0.22 mg and 0.93 mg of pancreatic juice. Therefore, from 
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Figure 4.13 - HPLC-DAD analysis of the precipitate obtained and the pancreatic juice (2,5 mg/ mL). 
Figure 4.12 - HPLC-DAD analysis of the SB supernatant (1,3 mg/ mL) and the pancreatic juice (2,5 mg/ mL). 
1 2 
0
50000
100000
150000
200000
250000
0 5 10 15 20 25 30
A
ve
ra
ge
 A
b
so
rb
an
ce
 (
m
U
A
)
Time (minutes)
Supernatant SB Pancreatic Juice
1 
52 
 
the total mass of the precipitate obtained, 17.1 mg corresponds to dietary fibers. 
Combining this result with the previous result of the mucilage precipitation method 
applied before to the artichoke fraction C (13.7 ± 2.1 %), the artichoke extract has 62.8 ± 
1.9 % of mucilage. 
Also, the precipitate formed had a low solubility, and not even with sonication and 
vortexing methods was possible to dissolve it in distilled water, which suggests that the 
majority of the precipitate obtained from the McCleary method were insoluble dietary 
fibers. 
  
4.3.1.3. Global composition 
The artichoke is a higher plant, which means that its cells walls are made up of 
aproximally 90% carbohydrates and 10% proteins, and it has in its constitution phenolic 
compounds and dietary fibers as well [11], [12]. Therefore, carbohydrates, proteins, 
polyphenols and soluble and insoluble fibers were measure in the artichoke extract to 
proceed to its characterization, being the results in Table 4.4. A total of 66.7% of the 
artichoke extract was characterized, being the soluble and insoluble fibers the most 
abundant compound of the Cynara C. var. Scolymus infusion, corresponding to 62.8% of 
it. The content of proteins showed to be the lowest, only 0.002%, which can be a result 
of the thermal process involved in the preparation of the artichoke infusion. Other studies, 
also reported a decrease of protein levels in vegetables after being boiled [13]. The levels 
of carbohydrates and phenolic compounds correspond to 0.82% and 3.06% of the 
artichoke extract, respectively.  
Table 4.4 - Quantity of carbohydrates, proteins, phenols and soluble and insoluble fibers present in a total of 80 mg of 
artichoke extract. The data are presented as the mean ± SD of at least 3 replicates experiments. 
 Carbohydrates Proteins Phenols Fibers Total 
Mass (μg) 661 ± 250 1.59 ± 0.92 2 452 ± 80.2 50 266 53 381 
% 0.82 ± 0.31 0.002 ± 0.001 3.06 ± 0.10 62.8 66.7 
 
Petacci et al. [14] quantified the polyphenols content of 12 Asteraceae species, including 
Ageratum Fastigiatum, Chromolaena Chaseae, Eremanthus Elaeagnus, Lepidaploa 
Lilacina, Lepidaploa Rufogrisea, Lychnophora Sp., Lychnophora Ericoides, 
Lychnophora Ramosissima, Mikania Nummularia, Trichogonia Villosa, Trixis Glutinosa 
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and Echinocoryne Holosericea, and their polyphenols content ranged between 32.65 ± 
0.70 and 147.97 ± 2.66 mg per 100 g of extract. On the other side, in this study the Cynara 
Cardunculus Scolymus, specie also from the Asteraceae family, showed 306 mg per 100g 
of extract, being a richer source of polyphenols.  
 
4.3.2. Artichoke Fraction A 
To evaluate the efficiency of polyphenols extraction from artichoke extract to the 
Artichoke Fraction A, samples of retentate and artichoke fraction A were collected before 
and after dialysis in order to perform a few quantifications. 
Analysis of the total phenols and tannins in all fractions showed that dialysis managed to 
extract phenols and tannins from the inside of tubing dialysis to the artichoke fraction A, 
being the results in Table 4.5.  
Table 4.5 - Concentration of total phenols and tannins in artichoke extract, digested artichoke extract before dialysis 
and in the retentate and artichoke fraction A after dialysis. The data are presented as the mean ± SD of at least 3 
replicates experiments. 
 Concentration (µg/mg of artichoke extract) 
 Artichoke 
Extract 
Digested artichoke 
extract 
Retentate 
Artichoke 
Fraction A 
Phenols 31 ± 1.0 16 ± 5 3 ± 0.5 35 ± 10 
Tannins 0.05 ± 0.002 0.02 ± 0.001 0.002 ± 0.0003 0.03 ± 0.009 
 
Previous studies using chokeberry reported no substantial effect caused by gastric 
digestion on any of the major phenolic compounds, including anthocyanins, flavonols, 
flavan-3-ols and caffeic acid derivatives [9]. However, in this study was observed a 
decrease of polyphenols concentration present in the artichoke extract from 31 ± 1.0 to 
16 ± 5 µg/mg of artichoke extract after the gastric digestion. Bouayed et al. [8] also 
reported a decrease of polyphenols in four apple varieties after gastric digestion when 
compared with their original content. Polyphenols and proteins, including enzymes like 
pepsin, can be bonded through reversible or irreversible non-covalent interactions, such 
as hydrogen bonding, hydrophobic and ionic interactions [15]. Therefore, the decrease 
observed may be due to these interactions.  
Afterwards, in the dialysis process was observed a decrease of polyphenols and tannins 
concentration in the retentate compared to the initial levels in the digested artichoke 
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extract (from 16 ± 5 to 3 ± 0.5 µg/mg of artichoke extract in total phenols; from 0.02 ± 
0.001 to 0.002 ± 0.0003 µg/mg of artichoke extract in tannins), and the opposite occurred 
in the artichoke fraction A, which levels increased (from 0 to 35 ± 10 µg/mg of artichoke 
extract in total phenols and to 0.03 µg/mg of artichoke extract in tannins). Notice that the 
levels of phenols and tannins are higher in artichoke fraction A than in the digested 
artichoke extract, suggesting that the interaction between polyphenols and proteins, such 
as pepsin, was reversible. The same happened between artichoke fraction A and artichoke 
extract, which suggests that a purification occurred, increasing polyphenols values per 
mg of artichoke extract. 
A quantification of chlorogenic acid, cynaroside and cynarin in the artichoke extract, 
digested artichoke extract, retentate and artichoke fraction A was also performed. These 
results are shown in Table 4.6. After acidic digestion, a decrease of chlorogenic acid and 
cynarin in the artichoke extract occurred, from 56 to 48 µg/mg of extract and from 83 to 
40 µg/mg of extract, respectively. On the other hand, an increase of cynaroside 
concentration was observed, from 7 to 33 µg/mg of extract. After dialysis, was observed 
a decrease of all components between the digested artichoke extract and the retentate, 
from 48 to 15 µg/mg of extract in chlorogenic acid, 33 to 3 µg/mg of extract in cynaroside 
and 40 to 28 µg/mg of extract in cynarin, which suggested that the transferring of these 
compounds occurred to the artichoke fraction A. This can be confirmed through the 
comparison of their values between the retentate and the artichoke fraction A, once 
occurred an increase of all in artichoke fraction A. 
Table 4.6 - Concentration of chlorogenic acid, cynarin and luteolin in digested artichoke extract before dialysis and in 
the retentate and artichoke fraction A after dialysis. 
 
Considering all results obtained, presented in Table 4.5 and Table 4.6, it is possible to 
conclude that this method was able to extract polyphenols, including chlorogenic acid, 
cynarin and cynaroside, from the artichoke infusion, which resulted in a purified fraction 
(artichoke fraction A). 
 Concentration (µg/mg of extract) 
 Artichoke 
Extract 
Digested 
artichoke extract 
Retentate Artichoke 
Fraction A 
Chlorogenic Acid 56 48 15 42 
Cynaroside  7 33 3 7 
Cynarin 83 40 28 71 
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The artichoke fraction A was lyophilized and a total mass of 572.8 mg was recuperated, 
but according to calculations, only 1.32 mg of polyphenols and tannins were extracted to 
this fraction. Therefore, the dialysis tubing allowed other artichoke compounds to pass to 
the permeate besides the polyphenols. These may be polysaccharides, so a mucilage 
quantification was performed and the results demonstrate that 22% of the lyophilized 
artichoke fraction A was mucilage. The same analysis was made for the lyophilized 
retentate and it showed that 33% were mucilage. The existence of mucilage inside and 
outside of the tubing dialysis probably happens due to size variances of the 
polysaccharides, being the molecular weight cutoff of 10 000 Da, meaning that only the 
molecules with a smaller size than 10 000 Da can pass through the pores to the artichoke 
fraction A. 
Initially were added 550 mg of artichoke extract, 35 mg of pepsin and 22 mg of sodium 
chloride, these last ones were part of gastric juice, to the dialysis membrane, resulting in 
a total mass of 607 mg. However, 43.6 mg of retentate and 572.8 mg of artichoke fraction 
A were recuperated after lyophilization, which equals 616 mg. Comparison of the initial 
mass with the recuperated showed a discrepancy of 9 mg. Lyophilization results in the 
absorption of 5-10% (w/w) of water by the dried mixture, so this difference observed 
maybe was due to its water content that wasn’t lyophilized [16].  
 
4.3.3. Artichoke Fraction B and C 
As showed in Figure 4.14, the chromatograms of both supernatants, are very similar, 
being only notable a slight difference within the peaks intensities. The same happened 
with the precipitates chromatograms as it is possible to observe in Figure 4.15. Therefore, 
the absence of acetic acid in the method used to precipitate the mucilage present in the 
artichoke extract doesn’t affect the composition of the supernatant and the precipitate. 
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Figure 4.14 - HPLC-DAD analysis of the artichoke fractions B and C. 
 
 
Figure 4.15 - HPLC-DAD analysis of the precipitates obtained from both methods, with and without acetic acid. 
 
An analysis of variance (ANOVA) showed that the levels of phenols and tannins present 
in the precipitates and supernatants obtained from both assays didn’t showed either 
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significant differences (p-value > 0.05) (Table 4.7), which means that the acetic acid 
doesn’t prevent the precipitation of these compounds along with the polysaccharides and 
proteins present in the mucilage. 
Table 4.7 - Quantification of total phenols and tannins in the supernatants and precipitates obtained with the mucilage 
precipitation methods with and without acetic acid. The data are presented as the mean ± SD of at least 3 replicates 
experiments. 
 Concentration (μg/ mg of artichoke extract) 
 Assay without acetic acid Assay with acetic acid 
 
Artichoke 
Fraction C 
Precipitate 
Artichoke 
Fraction B 
Precipitate 
Total Phenols  28 ± 3.5 4 ± 0.8 27 ± 2.1 4 ± 0.1 
Taninns 1.8 ± 0.3 0.3 ± 0.04 2.0 ± 0.5 0.3 ± 0.1 
 
In Table 4.8 is shown the quantification of chlorogenic acid, cynarin and cynaroside in 
the artichoke fractions B and C. Artichoke fraction C proved to be the richer fraction in 
chlorogenic acid, cynarin and cynaroside.  
Table 4.8 - Quantification of chlorogenic acid, cynarin and cynaroside in the artichoke fractions B and C. 
 Concentration (µg/mg of extract) 
 Artichoke Fraction B Artichoke Fraction C 
Chlorogenic acid 63 68 
Cynarin 82 83 
Cynaroside 14 18 
 
The acetic acid in this method is commonly used to free the polysaccharides from the 
salts and to recover them by precipitation through the addition of ethanol. However, the 
results obtained from both chromatograms, from total phenols and tannins quantification 
and from the quantification of selected polyphenols, showed no differences between 
artichoke fractions B and C obtained from both mucilage precipitation methods, with and 
without acetic acid. Considering these results and taking into account the purpose of these 
compounds and their costs of production, the artichoke fraction C was the fraction that 
appeared to have more potential. Therefore, this fraction was studied more deeply.  
In order to analyze the separation of the artichoke compounds by the mucilage 
precipitation method with no use of acetic acid, an analysis of the artichoke fraction C 
and the precipitate obtained from this procedure was performed by HPLC-DAD. In the 
chromatograms of Figure 4.16, the differences between the supernatant and the 
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precipitate obtained from this purification process are observed. Through a meticulous 
analysis, it’s possible to spot the same peaks in both chromatograms, which means that 
artichoke extract compounds were dragged along with the mucilage, resulting in their 
precipitation too. 
 
In Table 4.9 is shown the quantification of chlorogenic acid, cynarin and cynaroside in 
the artichoke fraction C and its precipitate. Artichoke fraction C retained most of the 
selected polyphenols during the mucilage precipitation (68 µg/mg of extract of 
chlorogenic acid; 83 µg/mg of extract of cynarin; and 18 µg/mg of extract of cynaroside), 
while its precipitate dragged along a small fraction of those polyphenols during 
precipitation (9 µg/mg of extract of chlorogenic acid; 16 µg/mg of extract of cynarin; and 
0.7 µg/mg of extract of cynaroside). The polyphenols precipitation may be due to the 
interactions between polyphenols and polysaccharides, which bond them forcing the 
polyphenols to precipitate along with the polysaccharides [17]. 
Table 4.9 - Quantification of chlorogenic acid, cynarin and cynaroside in the artichoke fraction C and its precipitate. 
 Concentration (µg/mg of extract) 
 Artichoke Fraction C  Precipitate 
Chlorogenic acid 68 9 
Cynarin 83 16 
Cynaroside 18 0.7 
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Figure 4.16 - Analysis of the artichoke fraction C and its precipitate by HPLC-DAD (1 mg/mL both). 
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The boiling point of ethanol is 78ºC [18], which is lower than the water boiling point 
(100ºC), so a strategy to eliminate the ethanol present in the supernatant through a 
washing process by a rotary evaporator was adopted, and a HPLC-DAD analysis of 
washed and unwashed artichoke fractions C was made to assure that this process wouldn’t 
change their composition, being the results in Figure 4.17. The chromatograms of both 
fractions are identical, having only different peaks intensities. Thus, the washing process 
didn’t affect the compounds present in the supernatants, being safe to use. 
Figure 4.17 - HPLC-DAD analysis of the artichoke fraction C washed and unwashed. 
 
A quantification of the total phenols present in the artichoke fraction C before and after 
this process was also done. As showed in Table 4.10, there was a loss of total phenols due 
to this process, but according to an analysis of variance (ANOVA), the difference isn’t 
significant (p-value > 0.05). Thus, the washed artichoke fraction C will be used in the 
following studies.  
Table 4.10 - Total phenols present in the artichoke fraction C before and after the wahing process. The data are presented 
as the mean ± SD of at least 3 replicates experiments. 
 Concentration (µg/mg of artichoke extract) 
 Artichoke Fraction C Washed Artichoke Fraction C Unwashed 
Total Phenols 22.7 ± 2.4 28.3 ± 3.5 
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4.4. Antioxidant Activities: DPPH Assays 
4.4.1. Artichoke Extract 
The effect of the artichoke extract in terms of the DPPH radical scavenging activity is 
represented in Figure 4.18. During the assay, the colors alterations between samples with 
different artichoke infusion concentrations were visible, implying the existence of 
antioxidant activity. The artichoke extract showed a clear dose-response scavenging 
effect on the free radical DPPH with a singular pattern. The antioxidant activity of 
artichoke extract obtained through DPPH method, expressed as the half maximal effective 
concentration (EC50), was 99 ± 29 µg/mL. Falé et al. [6] obtained an EC50 of 123.1 ± 5.7, 
which is higher than the result obtained in this study. 
Figure 4.18 - Antioxidant activity of artichoke extract. The data are presented as the mean ± SD of at least 3 replicates 
experiments. 
 
4.4.2. Artichoke Fraction A 
Artichoke Fraction A showed a clear dose-response scavenging effect on the free radical 
DPPH, indicating an antioxidant capacity, being the results in Figure 4.19. The 
antioxidant activity, expressed as the quantity of extract necessary to decrease the initial 
DPPH radical concentration by 50% (EC50), obtained for the artichoke fraction A was 95 
± 1.5 µg/mL. Due to the percentage stabilization, the value of antioxidant activity was 
taken directly from the graphic instead of the trendline equation.  
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4.4.3. Artichoke Fractions B and C 
In Table 4.11 are the results for the artichoke fractions B and C antioxidant activities, and 
as it shows, the purify fraction with the best antioxidant activity was the artichoke fraction 
C (56 ± 6 µg/ mL) (Figure 4.20), while the artichoke fraction B had a poorer antiradicalar 
activity (67 ± 6 µg/ mL) (Figure 4.21). 
Table 4.11 - Half maximal effective concentration (EC₅₀) of the artichoke fractions B and C obtained from the assays 
with and without acetic acid. The data are presented as the mean ± SD of at least 3 replicates experiments. 
 Artichoke Fraction C Artichoke Fraction B 
EC50 (μg/ mL) 56.1 ± 6.05 66.5 ± 5.90 
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Figure 4.19 - Antioxidant activity pattern of Artichoke Fraction A abtained from dialysis. The data are presented as 
the mean ± SD of at least 3 replicates experiments. 
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Figure 4.20 - Antiradicalar activity (%) of the artichoke fraction C. The data are presented as the mean ± SD of at 
least 3 replicates experiments. 
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4.4.4. Ascorbic Acid 
Ascorbic acid was chosen as the antioxidant reference for this test, so it was needed to 
perform a DPPH assay with this antiradicalar compound. In Figure 4.22 is represented 
the antioxidant activity of the ascorbic acid, which EC50 obtained was 2.8 ± 0,1 µg/ mL, 
which is similar to the results of other studies [21], [22]. 
Figure 4.22 - Antioxidant activity of ascorbic acid. The data are presented as the mean ± SD of at least 3 replicates 
experiments. 
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Figure 4.21 - Antiradicalar activity (%) of the artichoke fraction B. The data are presented as the mean ± SD of at least 
3 replicates experiments. 
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The antioxidant activity of ascorbic acid is the highest when compared with the results of 
the artichoke extract and the fractions obtained from purification methods (Figure 4.23). 
However, the ascorbic acid is a pure compound, while the artichoke extract and the 
fractions are complex mixtures of several components.  
 
 
4.5. Discussion 
Overall, both methods tested to purify the artichoke extract in order to potentiate its 
capacities, dialysis and mucilage precipitation method without the use of acetic acid, were 
successful, being the results in Table 4.12.  
Table 4.12 - Total content of chlorogenic acid, cynarin and cynaroside in the artichoke extract, artichoke fraction A 
obtained from dialysis and artichoke fraction C obtained from the mucilage precipitation method with no use of acetic 
acid, and their antioxidant activity. The data are presented as the mean ± SD of at least 3 replicates experiments. 
 Artichoke 
extract 
Artichoke 
Fraction A 
Artichoke 
Fraction B 
Artichoke 
Fraction C 
Total Phenols 
(µg/mg of extract) 
31 ± 1 35 ± 10 27 ± 2.1 23 ± 2.4 
Chlorogenic Acid 
(µg/mg of extract) 
56 42 63 68 
Cynarin (µg/mg of 
extract) 
83 71 82 83 
Cynaroside (µg/mg 
of extract) 
7 7 14 18 
Antioxidant 
Activity (µg/mL) 
99 ± 2 95 ± 1,5 67 ± 6 56 ± 6 
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Figure 4.23 - Antioxidant activities of artichoke extract, artichoke fractions A, B and C, and ascorbic acid The data are 
presented as the mean ± SD of at least 3 replicates experiments. 
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The polyphenolic content of artichoke extract increased after the acidic digestion and 
dialysis (31 ± 1 to 35 ± 10 µg/mg of extract), and decreased after the mucilage 
precipitation (31 ± 1 to 27 ± 2.1 and 23 ± 2.4 µg/mg in the case of the assays using and 
not using acetic acid, respectively). After dialysis, was observed a decrease of chlorogenic 
acid and cynarin after acidic digestion and dialysis, from 56 to 42 µg/mg of extract and 
from 83 to 71 µg/mg of extract respectively, while cynaroside concentration was 
maintained (7 µg/mg of extract). After mucilage precipitation, almost all compounds 
suffered an increase in the artichoke fractions B and C comparing with their original 
content in artichoke extract (from 56 to 63 and 68 µg/mg of extract in chlorogenic acid; 
from 83 to 82 and 83 µg/mg of extract in cynarin; and from 7 to 14 and 18 µg/mg in 
extract of cynaroside). In the three cases, the antioxidant activity improved from 99 
µg/mL (artichoke extract) to 95 µg/mL in the artichoke fraction A resulted from dialysis, 
and to 67 and 56 µg/mL in the artichoke fractions B and C, respectively, obtained from 
the mucilage precipitation method.  
Observing the results of  Table 4.12, the mucilage precipitation method with no use of 
acetic acid appears to be more effective in improving the artichoke extract antioxidant 
activity. It was able to increase the antioxidant capacity over 40%. Therefore, the 
artichoke fraction C was the purified fraction chosen to continue the study and to be 
incorporated in the topical formulations.  
 
4.6. Extracts Cytotoxicity 
Cell-based assays are used to determine if a compound has effect on cell proliferation or 
direct effects that lead to cell death. In order to study the artichoke extract and the 
artichoke fraction C cytotoxicity, the MTT assay was performed using HaCaT cells, a 
spontaneously immortalize human keratinocyte cell line. In the MTT assay, the viable 
cells with active metabolism are capable of converting the MTT into a purple compound, 
the formazan, while the dead cells are incapable of converting it, which allows the 
quantification of viable cells [19]. The results of this assay are shown in Figure 4.24. 
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Figure 4.24 - Cytotoxicity of artichoke extract (black bar) and artichoke fraction C (square bar) (1 mg/mL). SDS 
(sodium dodecyl sulfate) (dots bar)) was used as positive control and the medium as negative control (horizontal risks 
bar). The data are presented as the mean ± SD of 6 replicates experiments. 
 
Artichoke extract and artichoke fraction C showed a cell viability of 18.3% and 21.3% 
respectively, while SDS showed 4.6% and the medium 100%. Both fractions showed 
cytotoxicity and significant differences (p-value < 0.05) according to an analysis of 
variance (ANOVA), when compared with the medium (negative control) and the SDS 
(positive control). However, the HaCaT cell lines are more sensible than actually skin, 
since skin has a functional barrier that prevents the total absorption of these compounds 
when applied to skin. The rate-limiting barrier to the absorption of topical cosmetics is 
the stratum corneum, due to its length, which comprehends the number of cell layers, the 
thickness, the cell size and the difficulty of this pathway that the substances have to cross 
[20]. 
The EC50 of each fraction was also determined, being the results in Table 4.13. The 
artichoke extract and the artichoke fraction C showed a cytotoxicity of 173 ± 1 mg/mL 
and 218 ± 1 mg/mL, respectively. Meaning that the artichoke fraction C is the fraction 
less toxic when in contact with HaCaT cells.  
 
Table 4.13 - Cytotoxicity of the artichoke extract and artichoke fraction C. The data are presented as the mean ± SD 
of at least 3 replicates experiments. 
 EC50 (µg/mL) 
Artichoke Extract 173 ± 1 
Artichoke Fraction C 218 ± 1 
 
0
20
40
60
80
100
%
 C
el
l V
ia
b
ili
ty
Artichoke Extract Artichoke Fraction C SDS Medium
66 
 
4.7. Antioxidant Activities: Reactive Oxygen Species (ROS) 
scavenging activity 
The anti-radicalar activity of the artichoke extract and the artichoke fraction C was tested 
in HaCaT cells exposed to H2O2. As a preliminary assay, it was tested whether the order 
of application in cells, samples 30 minutes before H2O2 or simultaneously, affected the 
response of ROS production by the cells. As showed in Figure 4.25, the application order 
doesn’t affect the production of ROS by the cells, once there are no significant differences 
between the same samples applied before or simultaneously with the hydrogen peroxide. 
Therefore, it was decided to apply the fractions and the hydrogen peroxide 
simultaneously.  
 
In order to study the ROS scavenging effect on the artichoke extract and the artichoke 
fraction C, the ascorbic acid was once again chosen as the antioxidant reference. As 
showed in Figure 4.26, both fractions revealed ROS scavenging activity when exposed to 
H2O2, a chemical compound responsible for inducing oxidative stress, at concentration of 
1 mg/mL. In the assays were the H2O2 was placed 30 minutes before the samples, 
artichoke extract, artichoke fraction C and ascorbic acid showed a 93.3, 94.1 and 96.3 % 
of reduction of ROS, respectively. When the H2O2 was applied simultaneously with the 
samples, the ascorbic acid showed again the highest percentage of reduction of ROS with 
94.9%, and the artichoke extract and the artichoke fraction C showed 92.5 and 93.1%, 
respectively. Analysis of variance (ANOVA) was performed to compare the two fractions 
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Figure 4.25 - ROS production after artichoke extract (black bars) and artichoke fraction C (square bars) (1 mg/mL) 
exposure to HaCaT cells in RPMI medium for 30 minutes before the addiction of H2O2 and at the same time. Ascorbic 
acid as a negative control (risks bars). The data are presented as the mean ± SD of at least 5 replicates experiments. 
67 
 
with the ascorbic acid, and the results showed significant differences in both cases (p-
value < 0.05). This analysis also showed significant differences between both fractions 
(p-value < 0.05). 
 
Figure 4.26 - ROS production of artichoke (black bar) and artichoke fraction C (squares bar) (1 mg/mL) in HaCaT cells 
in RPMI médium in presence of H2O2. Ascorbic acid was used as a negative control (risks bar). The data are presented 
as the mean ± SD of at least 10 replicates experiments. 
 
Another assay was performed, in this case was used UVB radiation, a physical inducer of 
antioxidant stress, being the results in Figure 4.27. The artichoke extract and the artichoke 
fraction C showed 92.8 and 94.2% of reduction of ROS, while ascorbic acid showed 
95.7%. In this case, the analysis of variance (ANOVA) didn’t revealed any significant 
difference (p-value > 0.05) between the fractions and the ascorbic acid, and between both 
fractions. 
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Figure 4.27 - ROS production of artichoke extract (black bar) and artichoke fraction C (squares bar) (1 mg/mL) in 
HaCaT cells in RPMI médium when the cells are exposed to UVB radiation for 15 minutes. Ascorbic acid (risks bar) 
was used as a negative control. The data are presented as the mean ± SD of at least 5 replicates experiments. 
 
Taking into account the previous assays, the artichoke extract and the artichoke fraction 
C have powerful ROS scavenging effects, once their results are very similar with the ones 
obtained for the ascorbic acid, a well-known antioxidant. It should be noted that both 
fractions studied before, artichoke extract and artichoke fraction C, are complex mixtures 
composed of several chemical compounds while the ascorbic acid is a pure compound, 
which makes the results obtained in these assays even more remarkable. 
 
4.8. Solar Protection Factor Assay 
Flavonoids are plant pigments that are synthesized from phenylalanine, and several 
studies showed that these compounds have a wide spectrum of pharmacological 
properties, including antioxidative, antiallergic, anti-inflammatory, antidiabetic, hepato- 
and gastro-protective, antiviral, and antineoplastic activities, being extremely important 
to human health [23]. Therefore, the content of flavonoids was measure in the artichoke 
extract and the supernatant and the results are showed in Table 4.14. 
Table 4.14 - Content of flavonoids in the artichoke extract and the artichoke fraction C. The data are presented as the 
mean ± SD of at least 3 replicates experiments. 
 Flavonoids (µg/mg of extract) 
Artichoke Extract  31 ± 2 
Artichoke Fraction C 39 ± 7 
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Sunscreens are usually composed of synthetic chemical filters with a high capacity to 
absorb sun light at the region of UVB (320–290 nm) and UVA (400–320 nm) spectrum. 
Due to all the adverse effects (e.g. estrogenic effects, disruption of human endocrine 
activity, among others) of these compounds, there is a need to reduce the filter 
concentration in sunscreen formulations without affect their properties. A solution to this 
problem is to use natural products with a great antioxidant capacity (e.g. green coffee) 
instead of chemical filters, which may improve the photoprotective activity of sunscreen 
formulations. In fact, these natural products show several advantages, such as the 
bioactivity, relative safety and achievement from renewable sources, low cost, besides 
the feasibility for application in a wide range of health care products. As several studies 
suggest that one of the functions of the flavonoids is to protect the plants from potential 
harmful solar irradiation [24], [25], artichoke extract and the supernatant, rich sources of 
flavonoids and polyphenols, are potential candidates to replace the chemical filters in 
sunscreen formulation [26]. The SPF determination for the artichoke extract and the 
supernatant are represented on Table 4.15. 
Table 4.15 - SPF found for the natural oils/extracts. The data are presented as the mean ± SD of at least 3 replicates 
experiments. 
Sample SPF 
Green coffee oil 5.03 ± 0.23 
Artichoke Extract 10.99 ± 0.29 
Artichoke Fraction C 10.20 ± 0.21 
 
The green coffee oil (GCO) was the chosen positive control, since there are several studies 
suggesting the use of GCO as a potential natural product for improving SPF in sunscreens 
formulations thus, allowing to decrease the concentration of chemical or physical filters 
in such formulations [27]–[29]. This natural oil showed a SPF of 5.03 ± 0.23, while the 
artichoke extract and the supernatant presented 10.99 ± 0.29 and 10.20 ± 0.21, 
respectively. An analysis of variance (ANOVA) was performed to compare both fractions 
with the GCO, and the results showed that there is a significant difference between them 
(p-values < 0.05), being the artichoke extract the compound with the highest SPF. 
Therefore, the artichoke extract and the supernatant appears to have an enormous 
potential to be applied in sunscreen formulations with the advantages that they are natural, 
harmless and powerful antioxidants, which prevents the ROS production due to solar 
radiation.  
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4.9. Topical Formulations Preparation 
4.9.1. Final Formulations 
The artichoke extract and the artichoke fraction C were chosen to be incorporated in 
topical formulations, as bioactive ingredients, and it was decided to develop two topical 
formulations for each fraction, a gel and a cream.  
As the purpose of this study is to analyze the properties of the formulations containing 
the bioactive ingredients when applied in human skin, then it was decided to use the less 
ingredients possible to avoid raising doubts about the results obtained for the artichoke 
extract and the artichoke fraction C. 
For both gels (containing the artichoke extract (AG) and the gel containing the artichoke 
fraction C (CG)), it was decided to use a well-known formulation with the only the basic 
ingredients. For the cream containing the artichoke extract (AC) and the cream containing 
the artichoke fraction C (CC), was decided to develop a new formula, and for that were 
chosen specific ingredients in accordance with the final formulation properties desired. 
The formulations details are fully described in Materials and Methods chapter. 
Besides the formulations containing the bioactive ingredients, a blank gel (BG) and a 
blank cream (BC) were also prepared following the formulations chosen for each one. 
These blanks were used as a control for the following studies. 
 
4.9.2. Physico-chemical characterization of formulations  
4.9.2.1. Rheology 
Rheology characterization is very important in cosmetics once it helps reaching the 
optimal formulation that would be appealing to the consumer, choosing the production 
equipment and packaging, studying the formulation stability and it is considered a 
parameter in quality control [30], [31]. Therefore, in order to study the ability of the 
topical formulations to resist structural breakdown when applied to the skin, a shear-rate 
profile was traced for each formulation prepared. The representative flow curves are 
shown in Figure 4.28 and Figure 4.29. Apparent viscosity decreases concurrently with 
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the increase of shear rate, meaning that all formulations prepared are considered 
shearthinning. 
 
 
In the case of the creams, the flow curves also exhibited hysteresis loops, meaning that 
the formulation suffers a structural breakdown when the stress is applied, and 
consequently the viscosity decreases, but the network is regenerated by energy 
interactions when the stress applied diminishes, and the original viscosity is restored. This 
behavior is typical of time-dependent fluids, since after a sufficient resting time, the 
Figure 4.28 - Flow curves of artichoke extract, artichoke fraction C and blank creams representing shear stress as 
function of shear rate. 
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Figure 4.29 - Flow curves of artichoke extract, artichoke fraction C and blank gels representing shear stress as function 
of shear rate. 
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original viscosity it recuperated. The viscosity values presented in Table 4.16 show that 
the artichoke fraction C cream is the most and the blank cream is the less viscous 
formulation. The polysaccharides present in the plant extracts are possible responsible for 
the rheology behavior observed, since these swell in contact with water [32]. Therefore, 
the emulsions with artichoke extract or artichoke fraction C incorporated showed high 
viscosity due to the polysaccharides swelled, while the blank showed the lowest viscous 
behavior because it didn’t have these compounds present in it. The results obtained are in 
accord once the artichoke fraction C is the richer fraction in polyphenols, and 
consequently, the most viscous formulation. The opposite was observed for the gel 
formulations, since the artichoke fraction C gel was the formulation that presented the 
lower and the blank the highest viscosity, as represented in Table 4.16. This behavior may 
be due to the different pH observed before the addition of sodium ions and to the sodium 
ions themselves, once pH and ionic strength are both parameters that can influence the 
rheology properties of carbopol gels [33].  
Table 4.16 - Apparent viscosity values calculated at 61,18s-1 of all formulations. 
Formulations Apparent Viscosity (Pa.s) at 68,18 s-1 
Artichoke Fraction C Cream 2.48 
Artichoke Cream 1.9 
Blank Cream 0.9 
Artichoke Fraction C Gel 17.8 
Artichoke Gel 20.4 
Blank Gel 32.4 
 
 
4.9.2.2. pH Values 
The pH value of the topical products is a very important parameter, since the pH value 
can influence not only the solubility and stability of the bioactive ingredient in the 
formulations but also its release from the vehicle and its penetration into the skin barrier 
[34], [35]. Therefore, it’s important to evaluate this parameter in each formulation 
produced. If it was out of the ideal pH range, it was corrected adding HCl (decrease pH 
value) or NaOH (increase pH value), depending of the pH value measured. The pH values 
of all formulations prepared are represented in Table 4.17 and all were between 5.4 and 
6.4, meaning that all fit well within the ideal pH range for the skin. 
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Table 4.17 - Determination of pH values of all formulations prepared at environment temperature. The data are 
presented as the mean ± SD of at least 3 replicates experiments. 
Formulations pH value 
Artichoke Cream 5.9 ± 0.4 
Artichoke Fraction C Cream 5.9 ± 0.8 
Blank Cream 6.4 ± 0.3 
Artichoke Gel 5.4 ± 0.2 
Artichoke Fraction C Gel 5.7 ± 0.4 
Blank Gel 5.4 ± 0.2 
 
4.9.3. Microbiological Control 
Cosmetics have several ingredients in their constitution that are carbon sources, like 
water, oil and glycerin, and nitrogen sources, like amino acid derivatives and proteins, for 
fungi, bacteria and others microorganisms. Microbiological contamination of cosmetics 
products can lead to their instability, loss of safety and even the loss of their active 
ingredients. Therefore, it’s necessary to use preservatives in cosmetics formulations in 
order to prevent the growth of bacteria or fungi. In the artichoke extract and supernatant 
formulations parabens, in particular methyl paraben and propyl paraben, were used. 
Besides that, the water activity (amount of water available for biological processes) in all 
formulations was reduced by adding glycerin, which has the capacity to bind with water, 
reducing this way the water available in the products, and consequently, naturally 
preserving the formulations from contamination [36]. 
Thus, a microbiological control is a regulatory requirement for cosmetics in order to 
ensure the microbial safety of the it, to maintain the its quality and specifications and to 
guarantee hygienic and high-quality handling [37]. 
Total aerobic microbial count (TAMC) and total combined yeasts and molds count 
(TYMC) tests were performed through the spread-plate method for each formulation, and 
the results showed less than 10 colonies in both tests, which resulted from environmental 
contamination, meaning that the result obtain in all cases was less than 100 CFU per gram 
or milliliter of product tested. This value is lower than the limit imposed by the ISO 
16212:2008 and ISO 21149:2006 defined for these products (Category 2), thus the 
products prepared are considered microbiologically safe.  
 
 
74 
 
4.9.4. Formulations Cytotoxicity 
To test the cytotoxicity of all formulations prepared, gels and emulsions, the cell viability 
was evaluated using HaCaT cell lines in a MTT assay. The results obtained for the 
formulations containing artichoke and artichoke fraction C were compared to their blanks, 
as showed in Figure 4.30.  
Figure 4.30 – MTT assay measurement of cytotoxicity of topical formulations containing the artichoke extract (black 
bars) and artichoke fraction C (squares bars) and their blanks (vertical risks bars). The data are presented as the mean 
± SD of 6 replicates experiments. 
 
The creams containing the artichoke extract and the artichoke fraction C showed 51% and 
49% of cell viability, respectively. While the gel containing the artichoke extract showed 
51% and the gel with the artichoke fraction C incorporated showed 47%. The cream blank 
showed 94% and the gel blank 90% of cell viability. Analysis of variance (ANOVA) 
showed that the emulsions containing the fractions weren’t significantly different 
between them (p-value > 0.05). However, a significant difference (p-value < 0.05) was 
noted between the emulsions containing the bioactive ingredients and the blank. The same 
results were obtained for the gels.  
All the formulations containing bioactive ingredients had a poorer cell viability compared 
to its blanks, which aren’t harmful to the cells taking into account each ingredient present. 
The formulations showed a cell viability around 50% when compared to its blanks. 
Therefore, these results show that AC, AG, CC and CG can preliminary be considered as 
safe.  
0
20
40
60
80
100
120
%
 C
el
l V
ia
b
ili
ty
BC AC CC BG AG CG
creams gels
BC – Blank Cream 
AC – Artichoke Cream 
CC – Artichoke Fraction C Cream 
BG – Blank Gel 
AG – Artichoke Gel 
CG - Artichoke Fraction C Gel 
75 
 
When compared the cell viability of both extracts and their corresponding formulations, 
it is possible to observe a substancial increase of the cell viability from the isolated 
fractions to the formulations, being the results in Figure 4.31. Analysis of variance 
(ANOVA) showed significant differences (p-value < 0.05) between the cell viability of 
extracts and their respective formulations. Therefore, the vehicle (emulsion or cream) is 
able to reduce the cytotoxicity of artichoke extract and artichoke fraction C.  
 
4.9.5. Effects on membrane integrity  
In order to evaluate the effects of the formulations containing the bioactive ingredients 
on the membrane integrity of cells, an assay using propidium iodide was realized. This 
compound has the can bind to cellular DNA and as it is impermeant to the plasma 
membrane, it has the ability to only enter and stain damaged cells. The results are showed 
in Figure 4.32. 
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Figure 4.31 - MTT assay measurement of cytotoxicity of artichoke extract (black bars) and artichoke fraction C (square 
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j 
Figure 4.32 – Propidium iodide assay measurement of cytotoxicity of topical formulations containing the artichoke 
extract (black bars) and artichoke fraction C (squares bars) and their blanks (vertical risks bars). The data are presented 
as the mean ± SD of 6 replicates experiments. 
 
Both blanks showed a relative propidium iodide (PI) uptake of 1. The gels with the 
artichoke extract and the artichoke fraction C incorporated showed a slightly higher 
relative PI uptake of 1.2 and 1.1, respectively. The creams containing the artichoke extract 
and artichoke fraction C showed a relative PI uptake of 1.2 and 1, respectively. Analysis 
of variance (ANOVA) showed that the cream containing the artichoke fraction C and the 
blank weren’t significant different between them (p-value > 0.05). However, a significant 
difference (p-value < 0.05) was noted between the emulsion containing the artichoke 
fraction and the emulsion blank. The creams containing the bioactive ingredients were 
also significant different between them. The same analysis showed that the gels 
containing the bioactive ingredients were significant different between them and when 
compared with their blank. 
Considering that the cell lines are a more sensitive system than the actual skin cells and 
that the differences between the AC and CC formulations and their blank isn’t substantial, 
the results showed that all formulations can be considered not harmful.  
 
4.10. Discussion 
Reactive oxygen species (ROS) scavenging activity, solar protection factor (SPF) and 
cytotoxicity were studied for the artichoke extract and artichoke fraction C in order to 
compare both extracts. These in vitro studies showed that both fractions had powerful 
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ROS scavenging effects either in the presence of H2O2 or UVB radiation, and that both 
had a similar SPF value (10.99 for artichoke extract and 10.20 for artichoke fraction C). 
Cytotoxicity assays revealed also a similar cell viability for both fractions (18.3% for 
artichoke extract and 21.3% for artichoke fraction C). Since the results in all assays were 
identical for artichoke extract and artichoke fraction C, it was decided to incorporate both 
in topical formulations.   
The topical formulations, a gel and a cream, containing the fractions were subjected to 
microbiological control, cytotoxicity and membrane integrity assays in order to evaluate 
their safety for human use. All formulations were considered safe in all assays realized.  
Artichoke extract and artichoke fraction C and their respective formulations exhibited 
similar results in all assays performed. However, the costs and time of production of both 
fractions are very different. Artichoke fraction C required a larger amount of time and 
money to be produced, once it needs to be subjected to several procedures, including the 
precipitation of mucilage, and the washing and lyophilization processes. Therefore, 
taking into account the results and the costs and time of production of each fraction, it 
was decided to use only the formulations containing the artichoke extract in the following 
in vitro and in vivo studies. 
 
4.11. In Vitro Studies: Reactive Oxygen Species (ROS) 
scavenging activity 
In order to study the ROS scavenging effect of the gel and the cream containing the 
artichoke extract, the ascorbic acid was once again chosen as the antioxidant reference. 
As showed in Figure 4.33, both formulations revealed ROS scavenging activity when 
exposed to H2O2. The artichoke extract gel, artichoke extract cream and the ascorbic acid 
showed a 92.8, 90.3 and 95.7% of ROS reduction, respectively. Analysis of variance 
(ANOVA) was performed and the results showed significant differences (p-value < 0.05) 
between both formulations and between each formulation and the ascorbic acid. 
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Another assay using UVB radiation as an inducer of antioxidant stress was performed, 
being the results in Figure 4.34. The artichoke extract gel, artichoke extract cream and 
the ascorbic acid showed an 80.5, 79.6 and 97.5 % of ROS reduction, respectively. 
Analysis of variance (ANOVA) was performed and the results showed significant 
differences (p-value < 0.05) between the both formulations and the ascorbic acid. 
However, no significant differences were observed between the gel and the cream 
containing the artichoke extract. In this assay, the gel containing the artichoke extracts 
revealed the highest antiradicalar activity. 
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Figure 4.33 - ROS production of artichoke extract gel (white bar with black dots) and artichoke extract cream (black 
bar with white dots) in HaCaT cells in RPMI médium in presence of H2O2. Ascorbic acid was used as a negative control 
(risks bar). The data are presented as the mean ± SD of at least 5 replicates. 
Figure 4.34 - ROS production of artichoke extract gel (white bar with black dots) and artichoke extract cream (black 
bar with white dots) in HaCaT cells in RPMI médium when the cells are exposed to UVB radiation for 15 minutes. 
Ascorbic acid was used as a negative control (risks bar). The data are presented as the mean ± SD of at least 5 replicates. 
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4.12. In Vivo Studies 
4.12.1. Human Repeat Insult Patch Testing (HRIPT)  
No evidence for the induction of allergic contact hypersensitivity was observed during 
the HRIPT assay, neither in the induction or in the challenge period. Therefore, the 
formulations showed very good skin compatibility and didn’t exhibited allergenic 
potential, which makes them skin-friendly and dermatologically safe products. 
 
4.12.2. Assessment of the protective effect against oxidative stress 
after UV radiation by chromameter evaluation 
UV radiation is one of the factors that induce photo damage in the skin due to the 
production of reactive oxygen species (ROS) also known as free radicals. To prevent the 
reactions of free radicals, the human body has developed defense mechanisms known as 
antioxidants, however they can be inhibited by UV radiation and increase the formation 
of more ROS.  
β-carotene is a Yellow chromophore molecule and when is oxidized by UV radiation it 
loses its chromophore capability and color. This discoloration can be monitored by 
colorimetry (b* parameter). Skin color is obtained using a tristimulus color analyzer that 
measures reflected color. The system uses β-carotene high sensitivity photocells filtered 
to match CIE standard. The measuring head contains a high-power xenon arc lamp which 
provides diffuse illumination from a controlled angle for vertical viewing and constant 
lighting on the object.  The system detects any slight deviation in the xenon’s light 
spectral distribution. The system provides data for the Luminance (L*), a* (red-green) 
and b*(blue-yellow) color distribution.  
The protective effect against oxidative stress was evaluated by a Minolta Chromameter 
CR-400 (Minolta, Japan) in order to obtain the b* color, which is a measure along the 
yellow-blue axis (positive b* relates to the amount of yellowness and a negative b* to the 
amount of blueness), before and after the application of the products, including the 
formulations containing artichoke extract. β-carotene was the chromophore chosen as a 
reference in this procedure. The results obtained for the b* color measurement in the first 
day (D0) and the last day (D28) of the study are presented in Table 4.18. 
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Table 4.18 - Summary results of the evolution of b* color (AU) during the HRIPT assay. 
  Time n Basal 
Before 
irradiation 
After 
irradiation 
b* 
Artichoke Gel + Β-
carotene 
D0 10 16,8 36,3 33,2 
D28 10 16,8 35,8 34,3 
Artichoke Cream + 
Β-carotene 
D0 10 16,9 41,6 38,6 
D28 10 16,9 40,0 38,1 
Control 
D0 10 14,8 40,0 38,2 
D28 10 15,0 36,6 36,0 
 
To evaluate the true anti-oxidant activity obtained in each area at the end of the study, a 
relative analysis regarding D0 was performed, being the results summarized in Figure 
4.35. A product shows antioxidant activity when a decrease in the oxidant activity of the 
UVA radiation occurs.  
Regarding the anti-oxidant capacity, the product artichoke extract gel presented an 87.0% 
decrease in the oxidant activity of the UVA radiation. At the same time, the product 
artichoke extract cream presented an 75.8% decrease in the oxidant activity of the UVA 
radiation. Analysis of variance (ANOVA) showed significant difference (p-value < 0.05) 
between artichoke extract gel and the control, and the opposite occurred for the artichoke 
extract cream. Therefore, the artichoke extract gel presented a true in vivo antioxidant 
activity.  
  
Figure 4.35 - Oxidant activity % change during the study after the exposure to artichoke extract gel (white bar with 
black dots) and artichoke extract cream (black bar with white dots). Mean values of all the subjects (n=10).  
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4.13. Discussion 
In the ROS scavenging activity assays using H2O2 as inducer of antioxidant stress, the 
artichoke extract showed a ROS reduction of 92.5%, while the gel and the cream 
containing it showed 92.8 and 90.3%, respectively. In the assays using UV radiation, 
artichoke extract, and the gel and cream containing it presented 92.8, 80.5 and 79.6% of 
ROS reduction. Overall, the artichoke extract resulted in a higher percentage of ROS 
reduction. This result is probably due to the availability of the artichoke extract, free form 
or incorporated in a matrix. Aqueous artichoke extract when applied in the cells allows 
the direct contact of artichoke extract in its free form with the cells, resulting in an 
immediate antiradicalar action. On the opposite, the matrices of the formulations, cream 
and gel, are able to retain the artichoke extract, releasing it slowly to the medium with the 
cells, thus the action of it in has less impact due to a more extended response.  
In vivo studies showed that the gel containing the artichoke extract presented an 87.0% 
decrease in the oxidant activity induced by UVA radiation, while the artichoke extract 
cream presented 75.8%. These results are in accordance with the ones obtained from the 
latest in vitro studies, since the gel with the artichoke extract incorporated showed the 
highest antioxidant capacity in both cases. Release profiles of the artichoke extract from 
both formulations can explain the differences of antioxidant activities observed between 
the cream and the gel. In this case, the matrix of the gel may be able to release the 
artichoke extract in a more efficient and faster way than the matrix of the cream. Patel et 
al. [38] studied the percentage of release of psoralen from two distinct formulations, a gel 
and a cream, and the results also showed a higher release profile of psoralen from the gel 
formulations than that from the cream formulations.  
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5. Chapter: Conclusion 
Cynara Cardunculus var. Scolymus is a rich source of polyphenols, which are responsible 
for its antioxidant properties, and it is highly produced by Mediterranean countries, such 
as France, Spain, Italy and Greece. Currently, plant extracts are being preferable to be 
used in cosmetics products due to the prohibition of the use of animal origin ingredients 
to an increase search for ecofriendly and sustainable products. Therefore, artichoke can 
potential be a specie of interest to be incorporated in cosmetic products with antioxidant 
purposes. 
The aim of this study was to investigate the antioxidant properties of artichoke extract 
and its use as a bioactive ingredient in topical formulations with antioxidant purposes.  
Infusion revealed to be an efficient procedure to extract bioactive compounds from 
artichoke bracts. Regarding polyphenols, an analysis of artichoke extract revealed the 
presence up to 56 of chlorogenic acid, 7 of cynaroside and 83 of cynarin, which values 
were expressed in µg/mg of artichoke extract. A characterization of artichoke extract 
showed that it is composed by 62.8% of fibers, 3.06 of polyphenols, 0.82% of 
carbohydrates and 0.002% of proteins. DPPH radical scavenging activity assay of 
artichoke extract was realized and it was obtained an EC50 of 99 µg/mL.  
Purification of artichoke extract through an acidic digestion with gastric juice followed 
by a 24 hours’ dialysis, which resulted in artichoke fraction A, proved to be efficient in 
improving polyphenols content, from 31 to 35 µg/mg of artichoke extract. However, the 
amount of extractives, expressed in µg/mg artichoke extract, decreased from 56 to 42 for 
chlorogenic acid, from 83 to 71 for cynarin and for cynaroside the value remained equal. 
Concerning its antioxidant activity, was recorded an improvement from 99 to 95 µg/mL. 
Mucilage precipitation method was tested using two different approaches, one using 
acetic acid and the other only using ethanol, which resulted in artichoke fractions B and 
C, respectively. Regarding polyphenols, artichoke fraction B exhibited 27 μg/ mg of 
artichoke extract and artichoke fraction C exhibited 23 μg/ mg of artichoke extract. DPPH 
assay revealed an EC50 of 67 and 56 to artichoke fractions B and C, respectively. A 
chemical analysis of artichoke fraction B revealed the presence of 63, 82 and 14 μg/ mg 
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of artichoke extract of chlorogenic acid, cynarin and cynaroside, respectively; artichoke 
fraction C revealed the presence of 68, 83 and 18 μg/ mg of artichoke extract of 
chlorogenic acid, cynarin and cynaroside, respectively.  
An overview of the results obtained from purification methods showed that artichoke 
fraction C was the fraction with better antioxidant activity. However, this was also the 
fraction with lowest phenolic content, despite the increased content of chlorogenic acid, 
cynarin and cynaroside. But since the main goal was to incorporate the fraction with better 
antioxidant properties in topical formulations with antioxidant purposes, the artichoke 
fraction C was the chosen one to proceed with the study.  
Cytotoxicity assays in HaCaT cell lines revealed that both fractions decreased cell 
viability to 18.3% in artichoke extract and 21.3% in artichoke fraction C. ROS scavenging 
activity assay using hydrogen peroxide and UVB radiation revealed powerful antioxidant 
activity for artichoke fraction C and artichoke extract. In the assay using H2O2, ascorbic 
acid reduced 94.9% of ROS, while artichoke extract and artichoke fraction C reduced 
92.5 and 93.1%, respectively. In the UVB radiation assay, significant differences (p-value 
< 0.05) between ascorbic acid, artichoke extract and artichoke fraction C weren’t 
observed; artichoke extract and the artichoke fraction C showed 92.8 and 94.2% of ROS 
reduction, while ascorbic acid showed 95.7%. Both fractions also revealed to be rich in 
flavonoids (31 μg/mg of extract for artichoke extract and 39 μg/mg of extract for artichoke 
fraction C) and to have solar protection factor, which values were found between 10 and 
11. 
Topical formulations, a cream and a hydrogel, were prepared and both fractions, artichoke 
extract and artichoke fraction C, were incorporated in them. A physical-chemical 
characterization was performed for each formulation and all products showed acid pH 
values and shearthinning behavior, thus they were considered suitable for skin 
application. Assays of cytotoxicity and effects on membrane integrity in keranocytes, and 
a microbiological control showed that all formulations were also suitable for topical 
application. 
Observing the results obtained in the analysis of both fractions and their respective 
formulations, and taking into account the costs and time of production of each fraction, 
formulations containing the artichoke extract, a cream and a hydrogel, were chosen to be 
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used in more in vitro studies and in vivo studies. In vitro studies included a ROS 
scavenging activity assay using hydrogen peroxide and UVB radiation, and in vivo studies 
included a Human Repeat Insult Patch Testing (HRIPT) and an assessment of the 
protective effect against oxidative stress after UV radiation by chromameter evaluation. 
In the in vitro studies using H2O2 as oxidative stress inducer, the gel and the cream 
containing the artichoke extract showed a ROS reduction of 92.8 and 90.3%, respectively. 
In the assay with UVB radiation, the gel showed 80.5% and the cream showed 79.6% of 
ROS reduction. Overall, the formulations presented a lowest antioxidant activity against 
both inducers when compared with the artichoke extract in its free form (92.5% for H2O2 
assay; 92.8% for the UV radiation assay). 
In vivo studies performed in volunteers demonstrated very good skin compatibility and 
no allergenic potential for both formulations, so they were considered dermatologically 
safe. Regarding antioxidant capacity, artichoke gel and cream exhibited an 87.0% and 
75.8% decrease in the oxidant activity of the UVA radiation, respectively. In this assay, 
the artichoke gel was the topical formulation that presented a true in vivo antioxidant 
activity. 
In both studies, in vitro and in vivo, the gel formulation presented the highest antioxidant 
activity, which can be explain by a higher release profile of the artichoke extract. 
Formulations containing artichoke extract proved to be suitable, safe and efficient for skin 
application and for antioxidant purposes. Therefore, the main goal of this thesis was 
accomplished. 
  
87 
 
6. Chapter: Annexes  
6.1. HPLC-DAD calibration curves for chemical 
characterization 
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6.2. Folin-Ciocalteau test calibration curve 
 
 
6.3. Prussian Blue test calibration curve 
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6.4. DNS test calibration curve 
 
 
6.5. Bradford test calibration curve 
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6.6. Flavonoids test calibration curve 
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